Skip to main content
Nature Communications logoLink to Nature Communications
. 2021 Dec 10;12:7208. doi: 10.1038/s41467-021-27406-1

Influence of the chirality of carbon nanodots on their interaction with proteins and cells

Huijie Yan 1,#, Michele Cacioppo 1,2,#, Saad Megahed 1,3, Francesca Arcudi 2, Luka Đorđević 2, Dingcheng Zhu 1,4, Florian Schulz 1, Maurizio Prato 2,5,6,, Wolfgang J Parak 1,5,, Neus Feliu 1,7,
PMCID: PMC8664908  PMID: 34893594

Abstract

Carbon nanodots with opposite chirality possess the same major physicochemical properties such as optical features, hydrodynamic diameter, and colloidal stability. Here, a detailed analysis about the comparison of the concentration of both carbon nanodots is carried out, putting a threshold to when differences in biological behavior may be related to chirality and may exclude effects based merely on differences in exposure concentrations due to uncertainties in concentration determination. The present study approaches this comparative analysis evaluating two basic biological phenomena, the protein adsorption and cell internalization. We find how a meticulous concentration error estimation enables the evaluation of the differences in biological effects related to chirality.

Subject terms: Biomaterials, Nanobiotechnology, Nanoparticles


Chirality is known to impact the biological activity of materials but concentration differences can often lead to errors in analysis. Here, the authors report on detailed concertation analysis of different chiral carbon nanodots to accurately investigate chiral effects on the protein absorption and cell internalisation.

Introduction

While chemically similar, molecular isomers with different chirality can have significant different biological impact, such as pharmaceutical effect or cellular toxicity17. This has been well investigated on the level of small organic chiral isomers, which are naturally existing or can be synthesized. In the last decades, the concept of chirality in biological interactions has gained ever more interest in the raising world of nanomaterials, such as nanoparticles (NPs) or assemblies of NPs815. Apart from some atomically defined metal clusters, NPs in general do neither possess a defined molecular formula or structural formula. As thus NPs of one type are not identical but will have a (narrow) size-, shape-, and charge-distribution, the question is if chirality on the size level of whole NPs plays a role with the NPs interaction with biology, such as protein adsorption and cellular uptake. In fact, reports exist in which adsorption of proteins, the so-called protein corona16 was found to depend on the chirality of the NPs1723. Previous studies on carbon nanodots (CNDs) have focused on studying the effect of opposite chiral carbon dots in their biocompatibility and toxicity to liver HepG2 cells9, stereoselective interaction with the prion protein24, tuning enzymatic activity2527, interaction with the Golgi apparatus28, studying their effect on plant growth29, as well as establishing methods for detecting the interaction between achiral carbon dots and proteins30.

For a quantitative analysis, there are several complications. As the NPs of one type will not be identical, but there will be a distribution of their properties, a potential effect of NPs of the same type but with different chirality might be at a lower level than the inhomogeneity in effect due to the distribution of NP properties. Also, differences in chirality may involve additional distributions in the NPs properties, such as size, optical properties, colloidal stability, etc., as two types of NPs with different chirality will originate from two distinct batches of synthesis. The paramount requirement for analyzing the effect of chirality on the interaction of NPs with biology thus will be NPs with narrow distributions of their properties. In addition, in order to directly compare the biological impact of NPs with different chirality a metric needs to be defined on how properties of different NPs can be compared at the same concentration. Given the fact that surface coatings modify the molecular weight of NPs31, it is not the same metric to measure at the same mass concentration or to measure at the same NP number concentration.

Here we report a detailed study on the error of quantification of the concentration of NPs with opposite chirality for the comparative analysis of their interaction with biology. We firstly analyze and evaluate different routes for the determination of NP concentration and consider the error of quantification for each route. Subsequently, we use such error as a threshold to evaluate if the biological variations could be related to merely difference of concentration, or to the chiral properties. The study reveals that only a proper quantification of NPs leads to attributable different biological responses to NPs with equal physicochemical properties except the chiral surface.

Results

Synthesis and characterization

Here we chose CNDs, i.e. quasi-spherical NPs with an amorphous carbon-rich core and diameter under 10 nm, as model system32. Our synthetic protocol consists of a microwave-assisted hydrothermal bottom-up synthesis using arginine (Arg) and ethylenediamine (EDA) as precursors33. The corresponding nitrogen-doped N-CNDs were shown to possess a nanoscale amorphous core that is covered by an amino-rich surface33,34. Additionally, by substituting ethylenediamine with chiral diamines, such as (R,R)- and (S,S)-1,2-cyclohexanediamine, chiral CNDs, termed here R-CNDs and S-CNDs, were prepared35. Electronic circular dichroism of R-CNDs and S-CNDs verified the mirror-image relationship between the two NPs (Supplementary Fig. 1). The basic physicochemical properties of these chiral and achiral CNDs have been demonstrated to be highly similar, such as their diameter as determined by atomic force microscope (dAFM = 2.47 ± 0.84 nm and 2.64 ± 0.89 nm for the N-CNDs and R/S-CNDs, respectively)32,34,35, while their structure and composition, as determined by Fourier-transformed infrared spectroscopy (FT-IR, Supplementary Fig. 2) and X-ray photoelectron spectroscopy (XPS, Supplementary Fig. 3) showed similar multiple oxygen and nitrogen functional groups between them32,34,35. However, the absorption and fluorescence emission properties of the three different CNDs (i.e. the achiral N-CNDs and the chiral R/S-CNDs) are different (Supplementary Fig. 4), due to the presence of different surface functionalities and/or emissive traps32,34,35. This introduces a general source of error.

Metric for comparing the different types of CNDs

As many biological responses to NPs are dependent on the NP dose (i.e. cellular uptake, toxicity, etc.), a metric is needed to apply the N-, S-, and R-CNDs at the same dose to allow for quantitative comparison. Due to the small size and the carbon composition of the CNDs, it is a big challenge to define a reliable metric and thus we will first discuss the different approaches in this regard. In this way, first, the error in not being able to apply the identical amount of N-, S-, and R-CNDs needs to be estimated. Only effects in biological response higher than the error in CND quantification may be considered a significant difference in the biological response to be related to the opposite chirality.

In order to determine number concentrations, i.e. the number of NPs per volume of solution or their molarity (with Avogadro’s number being the scaling factor between these two entities), the NPs in a fixed volume of solution need to be counted. For big enough NPs counting can be performed easily with optical microscopy36. Due to their small size this however is not possible for the CNDs. In principle, small NPs can be counted by immobilizing them on a surface (optionally with evaporation of the solvent) and by imaging them with high-resolution microscopies, such as atomic force microscopy (AFM) or transmission electron microscopy (TEM). Note that for such single NP imaging, the resolution of the microscope given by the refraction limit does not necessarily need to be better than the size of the NPs. By working with strongly diluted solutions statistically each signal comes from an individual NP and agglomerates can be excluded, and thus counting of NPs can be performed without being able to resolve them. However, as in this case the number of NPs per image is low, there is a huge error in the counting statistics. In the case of the CNDs investigated in this study the relative error in counting, which determines the uncertainty in concentration determination is ΔCCNDs CCNDs–1 = 43% (Supplementary Table 1). We performed also counting of the CNDs with TEM, which was complicated by their low contrast due to their carbon composition. As TEM with improved refraction limit allows for resolving of individual CND here higher CND concentrations could be used and thus the number of CND counted per image could be increased. However, here agglomeration of the CNDs on the TEM grid occurred, and the relative error in counting, which describes the uncertainty in concentration determination was determined to be ΔCCNDs CCNDs–1 = 68% (Supplementary Table 2). Another common way for NP counting is nanoparticle tracking analysis (NTA). However, the here used CNDs are below the size limit recommended by the manufacturer of the frequently used Nanosight instrument (the manufacturer Malvern Panalytical recommends NPs > 10 nm diameter) and due to their low fluorescence emission intensity individual CND does not provide sufficient signal to be detected. Only rare agglomerates of CND are detected, leading to artificial huge hydrodynamic diameter (Supplementary Fig. 5). Thus, for the here used CNDs standard NP counting methodologies cannot be applied due to the huge experimental error.

An often-used alternative method to NP counting for the determination of NP concentrations is mass determination. In case of metal NPs the elemental amount of metal from the NPs and thus their concentration can be conveniently determined for example with inductively coupled plasma mass spectrometry (ICP-MS)37. However, ICP-MS is not a convenient method for carbon-based NPs such as the here investigated CNDs. Also, simply adjusting the samples to the similar weight of the CNDs is not possible, as apart from experimental errors (limits in the precision of weighting the CND powder; association of water by the hygroscopic CND powder, etc.) the N-, S-, and R-CNDs as prepared in three different syntheses will not have precisely the same mean mass per NP and also the mass distribution of the different samples will not be identical.

For this reason, here concentration determination of the CNDs was performed based on their optical properties, i.e. molar extinction coefficient and quantum yield. Due to different absorption spectra and fluorescence emission intensities, it is however not possible to simply prepare CND samples of similar doses by adjusting the respective concentrations to yield solutions with the same absorption or fluorescence intensity. In order to estimate the error in concentration determination, we plotted the absorption at 280 nm (A280) and the integrated fluorescence emission intensity Imax from 425 to 475 nm upon excitation at 405 nm of the CND samples of three different batches at different mass concentrations CCNDs, which were determined by dissolving CND powder of know mass in a known volume of Milli-Q water (Fig. 1). Note that these measured absorptions and emissions are not entirely linear38, which introduces an additional complication. The maximum difference in concentrations for the same sample, determined with the two methods, was considered as an error in concentration determination ΔCCNDs CCNDs–1 = 18% (Table 1). In total, five different batches were analyzed and the mean error in concentration determination was found to be ΔCCNDs CCNDs–1 = 22% (Supplementary Table 3). This error is clearly better than the errors obtained by AFM and TEM counting and thus, in our hands, the best way to determine the CND concentrations. Consequently, only biological effects bigger than 22% of the different CND samples will be considered to be significantly above the error in concentration determination.

Fig. 1. Carbon nanodots concentration determination through UV-Vis and fluorescence emission spectrophotometry.

Fig. 1

a Sketch of the N-, S-, and R-CNDs. b Absorption A280 at 280 nm of CNDs dissolved in water at the mass concentration CCNDs (determined by weighting). The A280(CCNDs) curve was fitted with linear regression to yield the slope ßA,j (mL μg–1) = ΔA280(j) ΔCCNDs–1 (j = R-CND, S-CND, N-CND). R2 indicates the fitting reliability with linear regression (perfect fit: R2 = 1). Data for the absorption at 405 nm (A405) are shown in Supplementary Fig. 6. c Integrated fluorescence emission Imax ranging from 425 to 475 nm (excitation wavelength λex = 405 nm) of CNDs dissolved in water at the mass concentration CCNDs. The Imax(CCNDs) curve was fitted with linear regression to yield the slope ßI,j (mL μg–1) = ΔImax(j) ΔCCNDs–1 (j = R-CND, S-CND, N-CND). From these slopes, first the percentual differences Δßi,j in the slopes between the R-CND and S-CND sample to the N-CND sample were derived for the absorption and intensity measurements as Δßi,j = (ßi,N-CND − ßi,j) ßi,N-CND–1 (i = A, I; j = R-CND, S-CND), and then the deviation Δßj in these differences between the absorption and intensity measurements were obtained as Δßj = |ΔßA,j − ΔßI,j| (j = R-CND, S-CND). The percentual error in concentration determination was defined as the maximum of these values as ΔCCNDs CCNDs–1 = max(ΔßR-CND, ΔßS-CND). The values are enlisted in Table 1. The shown data were obtained with batch #1.

Table 1.

Error analysis in concentration determination by absorption (A280(CCNDs)) and fluorescence intensity (Imax(CCNDs)) measurements.

ßA,R-CND (mL μg–1) ßA,S-CND (mL μg–1) ßA,N-CND (mL μg–1) ßI,R-CND (mL μg–1) ßI,S-CND (mL μg–1) ßI,N-CND (mL μg–1) ΔßA,R-CND ΔßA,S-CND ΔßI,R-CND ΔßI,S-CND ΔßR-CND ΔßS-CND ΔCCNDs CCNDs–1
0.00177 0.00225 0.00270 569422 842279 1187647 0.34 0.17 0.52 0.29 0.18 0.13 0.18

The parameters are defined in Fig. 1. The shown data were obtained with batch #1.

To probe the interaction of the CNDs with proteins and cells, the CND samples were adjusted to have the same absorption at 280 nm. As the R-, S-, and N-CNDs at the same concentration CCNDs as determined by weighting have slightly different absorption (Fig. 1b), we diluted the two samples with higher absorption than the third sample, until the R-, S-, and N-CNDs samples had the same absorption intensity at 280 nm. Upon dilution, the mass concentration of the CND samples has been slightly changed. We thus refer to the concentrations of the CNDs in the following as adjusted concentrations CCNDs, which refers to their absorption value. For the undiluted sample CCNDs = CCNDs, for the samples diluted to match the absorption, the adjusted concentration CCNDs is defined as equal to CCNDs of the undiluted sample. For details, we refer to Supplementary Fig. 7.

For the uptake studies, the amount of internalized CNDs was quantified by their fluorescence. However, as the different types of CNDs have different quantum yields, from the absolute detected fluorescence intensity I as detected for the different CND samples, the CND concentration CCND (which is proportional to their absorption) could not be directly derived. Thus, a correction factor X had to be applied (Supplementary Table 4, Supplementary Figs. 8 and 9), that the different CND samples had the same fluorescence I′ = X × I at the same concentration CCND. Note that the correction factor X had to be determined in the cell culture medium and for the used devices with which fluorescence was detected (i.e. fluorescence spectrometer, flow cytometry, confocal microscopy). Also, background correction was applied. Only by using this double correction (CCND → CCND and I → I′) the uptake of CND by cells could be compared for the different types of CNDs.

Role of the protein corona

As first impact of the interaction of the CNDs with biology, we chose the adsorption of different proteins. By measuring protein concentration-dependent size increase of the CND−protein conjugates by fluorescence correlation spectroscopy3941, absolute quantifiers describing the interaction could be obtained, namely the apparent dissociation constant KD, the maximum number of proteins Nmax that can bind per CND based on the Hill model, and the maximum size increase in hydrodynamic radius Δrh,max upon protein adsorption. KD describes the protein concentrations at which half of the CND surface is covered with proteins. As model proteins, three representative serum proteins, i.e. human serum albumin (HSA), alpha microglobulin (α2M), and transferrin (Tf) were used. Data of batch #1 are shown in Fig. 2, and the data of the other two batches are depicted in Supplementary Fig. 10.

Fig. 2. Change of hydrodynamic radius rh of CNDs (batch #1) as recorded in phosphate-buffered saline (PBS) in dependence of the protein concentration.

Fig. 2

a HSA; b Tf; c α2M. From the plots the fit parameters KD, Nmax, n, rh,0, and Δrh,max were obtained, which are listed in Table 2. Kd is the apparent dissociation constant of the CND-protein complex, Nmax is the maximum number of bound proteins per CND under saturation conditions, n is the Hill coefficient, rh,0 is the hydrodynamic radius of the CNDs without attached proteins, and Δrh,max is the difference in effective hydrodynamic radius between CNDs saturated with proteins and CNDs without attached proteins. The shown data were obtained with batch #1. Results are shown as mean values with error bars (i.e. the corresponding standard deviations) from three independent samples (n = 3) over three independent experiments.

The data shown in Fig. 2 indicate that proteins in general only weakly bind to the CNDs. The KD value gives the protein concentration, which is needed to half-saturate the CND surface (i.e. to have half of the maximum possible number of bound proteins). In comparison to other NPs the KD values are higher, meaning that the CNDs are worse binders for the proteins than the other NPs. In the case of HSA KD values of around 5.1 μM have been obtained for polymer-coated FePt NPs39,42, which is lower than the 〈KD〉 of 32.3 μM (Table 2) of the CNDs. Transferrin binds only weakly to the CNDs and under the explorable concentration range no saturation could be achieved, meaning that 〈KD〉 > 1000 μM. This is much higher than KD values of around 26 μM40,42, which have been obtained for polymer-coated FePt NPs. Alpha microglobulin does not adsorb to any of the tested CND surfaces within the tested concentration range. Thus, as with Tf, no quantitative values could be detected for the KD value, which will be >1000 μM. Only HSA resulted to adsorb sufficiently well to all CND surfaces and only for this protein a quantitative analysis based on KD was possible. The derived parameters for HSA for N-, S-, and R-CNDs of the three different batches are enlisted in Supplementary Table 5. A possible interference for quantitative analysis of the binding of proteins to NP surfaces is NP agglomeration4345. In case the size increase of the NPs upon adsorption of protein is much bigger than the size of the proteins (note that in many cases a monolayer adsorption of proteins covering the NP surface has been described), then this may be due to agglomeration effects. As shown in Table 2 (and Supplementary Table 5), the maximum change in hydrodynamic CND radius upon saturation of the CND surface with HSA (Δrh,max) is around 2.5 nm (Supplementary Table 5), which corresponds to the size of one HSA molecule, in good agreement with previous studies39,46. Of note, the size of one HSA molecule is much bigger than the size of one CND with a hydrodynamic radius of rh,0 of around 0.7–1.0 nm (Supplementary Table 5). Due to the small size of the CNDs one CND can adsorb only 1–2 HSA molecules (Nmax, Table 2 and Supplementary Table 5). We note that there is variation in KD values between the different CND batches (Supplementary Fig. 10 and Supplementary Table 5). In fact, for batch #2 and batch #3 under the explorable HSA concentration range, no saturation of the CND surface with HSA could be reached, i.e. the rh(cHSA) curves did not reach saturation. Under these conditions, the determination of KD values is extremely prone to errors (Supplementary Table 5), and thus we only considered the values of batch #1 (Table 2) for quantitative analysis. However, the batch-to-batch variability has to be taken into account when discussing the biological significance of the results. The data reported in Table 2 demonstrate that S-CNDs are significantly worse binders to HSA than R-CNDs (batch #1: KD of 39.9 μM versus 22.7 μM). The difference between both is ΔKDKD–1 = 0.36, which is bigger than the error associated with determining the CND concentration ΔCCNDs CCNDs–1 = 22% (Supplementary Table 3), though the CND concentration does at any rate only moderately influence the results for the KD determination41. As mentioned, as no saturation of the CNDs of batch #2 and batch #3 with HSA could be achieved these KD values are unreliable. Still, also for batch #2 and batch #3 the KD value for R-CNDs is lower than for S-CNDs. The HSA data for the N-CNDs are in the middle for batch #1. However, for batch #2 and batch #3 the KD values seem to be much higher than for the R-CNDs and S-CNDs in these batches (Supplementary Table 5). Again, as saturation of the CNDs with HSA is not though out of three CND batches only one could be quantitatively evaluated. Of note, for these batches (#2 and #3) also the hydrodynamic radii rh,0 of the N-CNDs are higher than in the other cases (Supplementary Table 5), which might be a reason for the different KD values. Also in the UV-Vis absorption spectra of batch #4 of the N-CNDs some agglomeration (e.g. scattering at high wavelength) is visible (Supplementary Fig. 11). Thus, protein adsorption on N-CNDs might be influenced by slight agglomeration and differences to the R- and S-CNDs cannot be unequivocally related to changes in chirality.

Table 2.

Parameters describing the interaction of CNDs and HSA.

CND type KD (μM) Nmax n rh,0 (nm) Δrh,max (nm) KD〉 (μM) ΔKDKD–1
R-CNDs 22.7 ± 5.3 1.2 ± 0.3 1.2 ± 0.2 0.69 ± 0.05 2.4 ± 0.1 32.3 −0.30
S-CNDs 39.9 ± 9.5 1.2 ± 0.3 1.2 ± 0.2 0.73 ± 0.04 2.3 ± 0.1 +0.24
N-CNDs 34.3 ± 10.4 2 ± 0.6 1.0 ± 0.1 0.73 ± 0.05 2.5 ± 0.1 +0.06

Apparent dissociation constant KD, maximum number Nmax of HSA molecules adsorbed per CND, cooperativity parameter n, hydrodynamic radius rh,0 of the CNDs without exposure to HSA, and maximum increase of hydrodynamic radius Δrh,max of the CNDs upon saturation with HSA. The error is the standard error as obtained by fitting of the data with the Hill-Model. ΔKD(S-CNDs) 〈KD–1 − ΔKD(R-CNDs) 〈KD–1 = 0.24 − (−0.30) = 0.54. Data were recorded with batch #1.

We thus can summarize that CNDs in comparison to other NPs are very weak binders to proteins, and from the three investigated proteins here only HSA formed a clear protein corona. For HSA there is a significantly better binding of R-CNDs to the CNDs than of S-CNDs. The HSA binding of N-CNDs had large batch−batch variations and there was the same agglomeration, and thus these data cannot be interpreted quantitatively.

We want to mention that our data refer only to three selected serum proteins. As with our method, i.e. FCS, we only detect changes in the hydrodynamic diameter upon protein adsorption, upon exposure to blood we would not be able to tell which proteins had adsorbed and caused the increase in size of the NPs. In order to detail the composition of the protein corona typically mass spectroscopy analysis is performed47. However, for such measurements first unbound excess proteins have to be removed. For the small CNDs as investigated here to which only few proteins can weakly bind, such purification may significantly change the protein composition left on the NP surface41. In contrast, diffusion measurements with FCS are performed in situ, without the need for purification. While such measurements do not allow for telling the composition of the adsorbed protein corona, and thus are best carried out in different solutions containing only one type of model protein, diffusion measurements can still verify protein corona formation in blood48.

Cellular uptake

Cellular uptake of the different types of CNDs (here batches #3, #4, and #5 were used) was quantified with previously established methods4951 with two cell lines (see “Methods”). HeLa cells were used as a standard model system, which is widely spread in general uptake studies52. As second system THP-1 macrophages as derived by the differentiation of the human monocytic leukemia cell line THP-153 were used, modeling an exposure scenario which CNDs could encounter in vivo. Viability assays were performed50, which demonstrated that under the used incubation conditions the CNDs are biocompatible (see “Methods”).

Uptake of CNDs by cells as quantified by the mean CND fluorescence I′ per cell was detected with two independent methods, flow cytometry (see “Methods”) and confocal microscopy (see “Methods”), as there may be discrepancies between the results of these two detection techniques54. Also, time- and concentration-dependence of CND uptake was quantified49, as well in serum-free as in serum-supplemented media. Probing such a range of different parameters serves as an internal control that CNDs were uptaken like other NPs. CNDs showed the expected general uptake behavior49: uptake of CNDs increased with increasing incubation times, with increasing CND concentration, and was higher in serum-free than in serum-supplemented medium (see “Methods”). In this way, differences in the uptake of the different types of CNDs are due to differences in the CNDs and not due to other factors. The main findings of the uptake quantification study are summarized in Fig. 3. Here the time-dependence of the uptake is shown. The corresponding concentration-dependence is presented in the “Methods” section. The data show that consistently there is (at the same incubation concentration CCND) lowest internalization of N-CNDs, and highest internalization for S-CNDs, as well for HeLa cells as for THP-1 derived macrophages (Fig. 3a versus Fig. 3b), quantified by both flow cytometry and confocal microscopy (Fig. 3b versus Fig. 3d). The question is now whether these differences in-between the different types of CNDs are significant. For this, the values at t = 48 h are analyzed in Table 3.

Fig. 3. Uptake of CNDs as quantified by the mean CND fluorescence I′ per cell.

Fig. 3

Cells were incubated for different times t at a CND concentration of CCNDs = 400 μg mL–1 in serum-supplemented (10% FBS) and serum-free medium. a HeLa cells, I′ detected by flow cytometry, see also Supplementary Fig. 22. b THP-1 derived macrophages, I′ detected by flow cytometry, see also Supplementary Fig. 24. c THP-1 derived macrophages, I′ detected by confocal microscopy, see also Supplementary Fig. 12. Results are shown as mean value ± standard deviation (s.d.) from three independent samples (n = 3) over three independent experiments. P values were analyzed by Student’s t test with two-tailed distribution and two-sample equal variance. *P < 0.05, **P < 0.01, ***P < 0.001.

Table 3.

Mean fluorescence intensity I′ detected per cell after t = 48 h incubation at CCNDs = 400 μg mL−1, corresponding to the last time point in Fig. 3.

Serum-supplemented medium Serum-free medium
HeLa THP-1 HeLa THP-1
Flow cytometry Flow cytometry Confocal microscopy Flow cytometry Flow cytometry Confocal microscopy
I′(R-CNDs) (a.u.) 798 480 30.2 971 492 46.4
I′(S-CNDs) (a.u.) 907 601 61.3 1065 654 112.5
I′(N-CNDs) (a.u.) 381 455 14.2 378 149 21.5
I′〉 695 512 35.2 805 432 60.1
ΔI′(R-CNDs) 〈I′〉–1 0.15 −0.06 −0.14 0.21 0.14 −0.23
ΔI′(S-CNDs) 〈I′〉–1 0.30 0.17 0.74 0.32 0.52 0.87
ΔI′(N-CNDs) 〈I′〉–1 −0.45 −0.11 −0.60 −0.53 −0.65 −0.64
ΔI′(S-CNDs) 〈I′〉–1 – ΔI′(R-CNDs) 〈I′〉–1 0.16 0.24 0.88 0.12 0.38 1.10

The full tables are provided in the Supplementary Information (Supplementary Tables 68). For all three types of CNDs the mean value for each incubation condition is given as 〈I′〉 = (I′(R-CNDs) + I′(S-CNDs) + I′(N-CNDs)) 3–1. Deviations are calculated as ΔI′(j) = (I′(j) − 〈I′〉)〈I′〉–1 (j = R-CND, S-CND, N-CND). ΔI′〈I′〉–1 = ΔI′(S-CNDs) 〈I′〉–1 − ΔI′(R-CNDs) 〈I′〉–1 tells the relative difference in fluorescence intensity per cell between S-CNDs and R-CNDs.

For N-CNDs there was always lower internalization than for S-CNDs and R-CNDs. As there was some agglomeration for the N-CNDs as discussed above this effect most likely is not related to the chirality of the CNDs, but to their colloidal stability, and thus will not be discussed further. For all investigated conditions there was more uptake for S-CNDs than for R-CNDs. Note, that the data shown in Table 3 are not “cherry-picked”, and in fact, under different CND concentrations the uptake difference between R-CNDs and S-CNDs was even higher (Supplementary Fig. 13). This is an important internal control, that results are not related to only one particular incubation condition but are valid in general. While the data shown in Fig. 3 and Table 3 show that S-CNDs internalize best, for making a final statement the differences in uptake need to be related to the experimental errors. For example, while for THP-1 derived macrophages the tendency as obtained from flow cytometry is the same as from confocal microscopy data, the difference between both types of CNDs is more pronounced for the confocal microscopy data. In Fig. 1 we pointed out that there is an uncertainty of CND concentration determination of ΔCCNDs CCNDs–1 = 22%. From Table 3 the difference in uptake between S-CNDs and R-CNDs for HeLa cells is ΔI′〈I′〉–1 = 16% and 12% for serum-supplemented and serum-free incubation conditions, respectively. According to our analysis the change in uptake difference for HeLa cells might be caused by uncertainty in concentration determination (ΔI′〈I′〉–1 < ΔCCNDs CCNDs–1) and thus no difference in the uptake behavior based on chirality should be claimed. In contrast, from Table 3 the difference in uptake between S-CNDs and R-CNDs for THP-1 derived macrophages is ΔI′〈I′〉 –1 = 24% and 38% for serum-supplemented and serum-free incubation conditions (flow cytometry data) and ΔI′〈I′〉–1 = 88% and 110% for serum-supplemented and serum-free incubation conditions (confocal microscopy data), respectively. Thus, these differences are clearly above the error of concentration determination (ΔI′〈I′〉–1 > ΔCCNDs CCNDs–1) and are thus related to the different chirality of the CNDs. As macrophages are designed to interact with “intruding” molecules/particles/materials, it is plausible that they can better distinguish “what to take up”, i.e. better differential of surface differences between S-CNDs and R-CNDs. We thus can summarize that for THP-1 derived macrophages there is significantly higher uptake from S-CNDs than for R-CNDs.

Apart from the uptake quantification we also performed colocalization assays and chemical blocker for known pathways of endocytosis (see “Methods”). All types of internalized CNDs colocalized to a high degree with lysosomes (Supplementary Fig. 15). Cellular uptake of the CNDs was blocked at 4 °C, suggesting that the internalization of the CNDs is an energy-dependent process (see “Methods”)55. The three types of CNDs were taken up by both different cell types largely via a phagocytosis pathway, while N-CNDs could also be endocytosed via a clathrin-associated endocytosis pathway, similar to the results obtained for the THP-1 derived macrophages (see “Methods”). The different cellular uptake behavior of the N-CNDs may be related to their lower colloidal stability.

Discussion

Correlating the interaction of NPs with cells with the physicochemical properties of the NPs is by far not trivial. Several physicochemical properties may be entangled56, and many time effects may not be due to a primary physicochemical parameter (such as e.g. chirality), but due to colloidal stability (as here in the case of the N-CNDs). In fact, we have shown here by FCS measurements that for the R- and S-CNDs chirality does not affect colloidal stability and only because for this case entanglement of chirality and colloidal stability was ruled out differences in biological effects can be related to chirality as physicochemical parameter. For the N-CNDs there was an effect on colloidal stability and thus differences in their biological effects cannot be related to their non-chiral nature.

For many types of NPs concentration determination is not unequivocal31, and thus errors in the metric (here ΔCCNDs CCNDs–1) need to be taken as threshold whether detected differences in the interaction of the NPs with cells can be related to certain physicochemical parameters. In the present case, the uptake of S-CNDs is significantly higher than that of R-CNDs for THP-1 derived macrophages, and differences in uptake can be related to the different chirality between both types of CNDs. For the case of HeLa cells, the same tendency was observed, but differences in uptake might be also due to uncertainties in concentration determination.

Taking into account the protein corona data, HSA binds significantly better to R-CNDs than to S-CNDs (Table 2: KD(R-CNDs) = 22.7 μM < KD(S-CNDs) = 39.9 μM). It is not directly obvious why the different chirality between R-CNDs and S-CNDs leads to different adsorption behavior of HSA, as concerning the chemical composition, charge, etc. but surfaces are identical. As the surface of the CNDs will not be smooth and homogenous, most likely the different chirality has some local effect on the arrangement of the organic shell, like a different local density of the functional groups or different local conformation, which would explain why HSA binds differently to both surfaces.

R-CNDs are endocytosed to a significantly lesser extent by THP-1 derived macrophages than S-CNDs (Table 3: I′(R-CNDs) < I′(S-CNDs)). An easy way to interpret this scenario could be the following. There is more protein corona for R-CNDs. The presence of a protein corona for many NPs is often associated with lower uptake by cells (in fact there is lower uptake in serum-supplemented conditions where a protein corona can be formed than in serum-free conditions), which would explain the reduced uptake for the R-CNDs. However, this interpretation might be too simple. In comparison to other NPs the CNDs are very poor binders to proteins, which will be influenced by their small size. Only for HSA, but not for Tf and α2M saturation in binding could be achieved (Fig. 2). However, also for HSA there is on average only one single HSA molecule associated with each CNDs (Table 2; Nmax parameter). Differences in uptake (ΔI′(S-CNDs) 〈I′〉–1 versus ΔI′(R-CNDs) 〈I′〉–1) were larger in serum-free than in serum-supplemented medium. While also under serum-free culture conditions presence of some proteins in the culture medium cannot be excluded, it is unlikely that at low protein concentrations (cp of proteins in serum-free medium ≪ KD) a difference in the attachment of proteins from the medium between S-CNDs and R-CNDs is the reason for their different uptake by cells, in particular as the CNDs are poor binders for proteins. The surface of cells is not homogeneous, and the lipid bilayer is patterned with proteins and sugars. Before a NP is internalized by a cell, it first needs to bind to the cell surface, where it may dwell for some time until it is endocytosed57. We thus speculate that in addition to protein corona-related effects there might be better (non-specific) adsorption of R-CNDs to the cell surface than of S-CNDs, which then would relate to higher uptake. This demonstrates that while the general picture of particle uptake is quite well established58, it is not that all details would be understood.

The data shown here demonstrate that also under most stringent considerations of errors in the concentrations determination of CNDs, it has been shown that chirality may affect the protein corona formation and in vitro cellular uptake of CNDs to an extent of >20%. It thus can be speculated that this difference would also influence the in vivo interaction of CNDs. Chirality itself does not influence the most important physicochemical properties of CNDs, such as fluorescence and colloidal properties. By using CNDs of different chirality thus different biodistributions of otherwise identical CNDs might be obtained.

Methods

Characterization and concentration determination of the CNDs

Basic optical characterization of the CNDs

Different carbon nanodots (CNDs) were synthesized according to previously published protocols, i.e. N-CNDs34, and R-CNDs and S-CNDs35. Firstly, the optical properties of the CNDs were characterized. Briefly, the obtained lyophilized solids of CNDs were first weighted and then fully dissolved in filtered Milli-Q water to form stock solutions with a concentration of CCNDs = 10 mg mL–1. Then, the stock solutions were further diluted to CCNDs = 100 µg mL–1 with filtered sterilized water for absorbance and fluorescence spectra measurements (Supplementary Fig. 4) using an UV-Vis absorption spectrophotometer (Agilent 8453, Agilent technologies, Australia) and a fluorescence spectrometer (Fluorolog-3, Horiba Jobin Yvon, USA). In the absorption spectra the R-CNDs and S-CNDs displayed two absorption peaks, while the N-CNDs only had one peak, at the same position as the R-CNDs and S-CNDs at 280 nm. Concerning the fluorescence properties, the three CNDs demonstrated a slight excitation-dependent emission shift upon excitation at different wavelength λex ranging from 330 to 440 nm.

Concentration-dependent absorption/fluorescence intensity measurements

In order to account for different absorption and emission properties of the different CNDs, the concentration-dependent adsorption and fluorescence spectra were measured for the different CND samples. For this objective, the CND solutions with concentrations ranging from CCNDs = 0.78 µg mL–1 to 400 µg mL–1 were prepared by diluting the CND stock solutions with filtered Milli-Q water. Then, UV-Vis absorption spectra A(λ) and fluorescence spectra I(λ) (λex = 405 nm) were recorded (Supplementary Fig. 26). The three different types of CNDs all possessed a dose-dependent absorbance and fluorescence behavior as expected, i.e. the adsorption and fluorescence linearly decreased with more diluted CNDs solutions. The absorption values A280 = A(λ = 280 nm) plotted against the CND concentration are shown in Fig. 1 in the main manuscript. In order to probe the influence of the wavelength at which the absorption is measured for the error analysis, the same evaluation as performed for Fig. 1b in the main paper was also performed for the absorption A405 at 405 nm of the CNDs (Supplementary Fig. 6). As A405 ≪ A280 all further evaluation was performed with A280.

Concentration adjustment and fluorescence intensity correction

As the CNDs at different mass concentration CCNDs (as determined by weighting) showed different absorption (Supplementary Fig. 6), the concentrations were adjusted to lead to the same absorption at 280 nm. This was done to allow further concentration determination via absorption measurements. For this, the adsorption values of the CND solutions were determined at 280 nm and the CND solutions with higher adsorption values (which was always the R-CNDs) were diluted with filtered Milli-Q water until achieving all samples had the same absorption A280. The R-CND solution remained undiluted at concentration CCNDs. In the following the adjusted concentrations of the S-CND and N-CND solutions were assumed to have the same concentration as the R-CND solution. Here the “same concentration” refers to equal absorption at 280 nm. These absorption-based concentrations are referred to as adjusted concentrations CCNDs. CCNDs(S-CNDs) = CCNDs(N-CNDs) = CCNDs(R-CND) = CCNDs(R-CND). An example is shown in Supplementary Fig. 7. In order to determine the error in concentration determination absorption A(λ) and emission spectra I(λ) were recorded in dependence of the adjusted concentrations CCNDs. The spectra are displayed for the five different batches of CNDs used in this study in Supplementary Figs. 18 and 19. The concentration-dependence of the absorption at 280 nm and of the fluorescence emission as derived from the spectra is plotted for all five batches in Supplementary Fig. 27. Based on Supplementary Fig. 23 error analysis was performed as described in Fig. 1 of the main manuscript, and the results are displayed in Supplementary Table 3. As can be seen in Supplementary Figs. 7 and 27 at the same adjusted concentration CCND the R-CND, S-CND, and N-CND samples have different fluorescence emission intensities. This needs to be considered when quantifying the uptake of CNDs by their fluorescence with flow cytometry and confocal microscopy. For flow cytometry was collected with a 450 nm/50 nm bandpass filter, and for confocal microscopy with an LP 420 nm long pass filter (Supplementary Fig. 7). In this way correction factors X taking into account the different fluorescence intensities at the same adjusted concentrations were defined. XS/R = 〈I(S-CNDs)〉 〈I(R-CNDs)〉–1 is the ratio of the integrated S-CND fluorescence and the integrated R-CND fluorescence, at the same adjusted concentration of S-CNDs and R-CNDs. The integration range was used emulating the flow cytometry and confocal microscopy filters. XS/N = 〈I(S-CNDs)〉 〈I(N-CNDs)〉–1 is the ratio of the integrated S-CND fluorescence and the integrated N-CND fluorescence, at the same adjusted concentration of S-CNDs and N-CNDs. The resulting values are enlisted for all five used batches in Supplementary Table 4.

Concentration determination by CND counting with atomic force microscopy (AFM)

Diluted CND solutions of concentration CCNDs of R-CNDs and S-CNDs were drop-casted on mica substrates for AFM analysis. Images were acquired by tapping mode AFM (Nanoscope IIIa, VEECO Instruments) on a surface area Ascan of 25 μm2 (Supplementary Figs. 28 and 29). The number NCNDs of CNDs as identified in the image (by looking at the height profiles) was counted for samples prepared by two concentrations per typology of CNDs (R- and S-) and is displayed in Supplementary Table 1. The respective mean values 〈NCNDs〉 and standard deviations ΔNCNDs were then calculated. Taking together all determined four values for ΔNCNDsNCNDs–1 leads to a mean value of ΔNCNDsNCNDs–1 ≈ 0.21. The normalized error in NP counting corresponds to the normalized error in concentration determination ΔcCND cCND–1. Note that the real error even might be higher. This point is better rationalized if we consider the mass per CND to compare the theoretical and calculated number of CNDs per substrate area. Considering the similar average size of CNDs we calculated the average NP mass of CNDs considering their sphericity and the density of amorphous carbon (ρC = 3.50 g cm–3)35. By calculating the expected and measured number of particles on substrate, 〈nCNDs〉 = 〈NCNDsA–1, is thus possible to make a direct comparison of the two quantities. As reported in Supplementary Table 1, the calculated and expected 〈nCNDs〉 values are different by several order of magnitude and this result may be influenced by the drop casting deposition process59 that could be cause of: (i) inhomogeneous distribution of NPs on the surface, (ii) formation of aggregates during the solvent evaporation. The following paragraph, treating the CNDs quantification trough transmission electron microscopy (TEM), further remarks the difficulty on calculating these NPs trough microscopy techniques using an analogous concept.

Concentration determination by CND counting with transmission electron microscopy (TEM)

Transmission electron microscopy (TEM) measurements to count CNDs were performed using a Jeol JEM-1011 instrument operating at 100 kV. 2 µL of the according CND solution (CCNDs(R-CNDs) = 2.0 mg mL–1; CCNDs(S-CNDs) = 2.8 mg mL–1) were drop-casted onto a copper grid (400 mesh, diameter 3.05 mm) coated with amorphous carbon. As can be observed from the TEM-micrographs shown in Supplementary Figs. 30 and 31, homogeneous coating was not achieved. For the R-CNDs different aggregates were observed, whereas for the S-CNDs some areas with dispersed CNDs were also found. It is not known, how much of the aggregates form during drying on the TEM grid. On both samples it was possible to differentiate single CNDs; however, due to the limited contrast, an exact determination of CND size was not possible. Based on micrograph analysis with ImageJ we obtained dTEM ≈ 1.5 ± 0.4 nm for R-CNDs (N = 216 CNDs investigated) and dTEM ≈ 2.4 ± 0.9 nm for S-CNDs (N = 255 CNDs investigated). These values are compatible with those obtained by AFM (dAFM) and discussed in the main text. We emphasize, however, that due to the limited number of observed CNDs and limited contrast, the diameters as determined with TEM should be considered a rough estimate. We used the determined CND diameters to calculate theoretical concentrations, assuming sphericity. With the density of amorphous carbon ρC = 3.50 g cm–3 (diamond has a similar density of ρC = 3.51 g cm−3) and the weight concentrations (CCNDs(R-CNDs) = 2.0 mg mL–1; CCNDs(S-CNDs) = 2.8 mg mL–1) we obtain a molar concentration of cCNDs ≈ 540 µM for R-CNDs and cCNDs ≈ 180 µM for S-CNDs. Because of the limited accuracy of CND diameter determination, also these concentrations must be considered as a rough estimate. In the TEM micrographs of S-CNDs we find 〈nCNDs〉 = 〈NCNDsAscan–1 ≈ 3014 CNDs µm–2 on average (Supplementary Table 2). For R-CNDs we find 〈nCNDs〉 ≈ 1920 CNDs µm–2 on average on the micrographs. The accuracy of the numbers is limited by the contrast, depending on the micrograph. The standard deviations ΔnCNDs for both average numbers are very high (Supplementary Table 2), with the mean value of both standard deviation being 0.68. This mean value for ΔnCNDsnCNDs–1 would correspond to the uncertainty in concentration determination ΔCCND CCND–1 = 0.68, underlining that the concentration determination with TEM is not feasible. Assuming a homogeneous coating of the whole TEM grid (area = 7.3 × 106 µm2) with these densities, one can estimate 2.4 × 1010–2.8 × 1010 CNDs in the dried 2 µL that were drop-casted onto the grids. This would correspond to cCNDs ≈ 10–20 nM solutions. As expected, this value is several orders of magnitude off the theoretical value, underlining that it is not feasible to obtain a meaningful CND concentration based on TEM analysis.

Concentration determination by using the nanoparticle tracking analysis (NTA)

Nanoparticle tracking analysis (NTA) was performed with a NanoSight LM10 (Malvern Panalytical) operated with a 405 nm laser. R-CND solution were diluted to cCNDs = 18 µM (see the respective section in “Methods”) and S-CNDs to cCNDs = 5.5 µM. As can be observed in Supplementary Fig. 5, only large aggregates were tracked by the system for both samples. The main population of CNDs is too small and scatters too weakly to be discernible with this technique. The CND concentrations (which are in fact aggregate concentrations) determined with NTA were nCNDs ≈ 3.4 × 107 CNDs mL–1 for R-CNDs and nCNDs ≈ 1.0 × 107 CNDs mL–1 for S-CNDs. This corresponds to concentrations in the femtomolar range, underlining that CNDs cannot be measured with NTA but also that the number of aggregates in the CND solutions seems negligible. Note that presence of agglomerates to a large extent can be ruled out by the FCS measurements shown in the respective section in “Methods”.

Other physicochemical characterization data

Additional standard characterization of the CNDs is provided in the form of Fourier-transform Infrared (FT-IR) spectra (KBr), shown in Supplementary Fig. 2, electronic circular dichroism (ECD) spectra shown in Supplementary Fig. 1 and X-ray photoemission spectroscopy (XPS) shown in Supplementary Fig. 3. FT-IR spectra were recorded on a Perkin Elmer 2000 spectrometer. ECD spectra were measured on a Jasco J-815. XPS spectra were measured on a SPECS Sage HR 100 spectrometer.

Influence of cell culture medium on the properties of the CNDs

While the characterization in the respective section about CND properties in “Methods” was carried out in water, uptake experiments of the CNDs took place in cell culture medium. Thus, it needed to be tested how the presence of cell culture medium affects the properties of the CNDs. For this, 400 µL of CND solutions (CCNDs = 200 µg mL–1) were mixed with the same volume of either (i) Milli-Q water (as the negative control), (ii) RPMI (Roswell Park Memorial Institute) 1640 medium without phenol red (Thermofisher, USA) supplemented with 10% fetal bovine serum (FBS, Biochrom, UK), and (iii) RPMI 1640 medium without phenol red without serum. Thus, the final CND concentration was CCNDs = 100 µg mL–1. After different incubation times of t = 0, 24, and 48 h, the CND solutions were characterized in a UV-Kuevette, ZH 8.5 mm Deckel (Sarstedt, Germany) with UV-Vis absorption spectroscopy and with fluorescence spectroscopy (λex = 405 nm). In addition, the hydrodynamic diameters dh of the CNDs in the different media were measured by dynamic light scattering (DLS, Malvern NANO ZS, England)60. In Supplementary Figs. 8, 9 and 32 the absorption and fluorescence spectra of the three different types of CNDs are shown. In all three cases there is a slight fluorescence increase of the different types of CNDs after incubation in particular in serum containing RPMI 1640 medium. At this increase is similar, fluorescence intensities of the three different types of CNDs (R-CNDs, S-CNDs, and N-CNDs) can be also directly compared when the CNDs are exposed to cell culture medium.

The hydrodynamic diameters dh of the CNDs after incubation with the different medium were measured after different time points by DLS. Data are shown in Supplementary Fig. 33. Due to the very small size of the CNDs and in the case of RPMI 1640 medium supplemented with 10% FBS due to the presence of proteins of similar size as the CNDs, the DLS values are unreliable and are not further interpreted in this study. In fact, the hydrodynamic diameter as detected in the plain media without proteins (yellow bars; water and RPMI 1640 medium without serum) most likely correspond to dust. The increase hydrodynamic diameters as detected in the serum-supplemented medium (yellow bars, RPMI 1640 medium with FBS) originate from serum proteins. Presence or absence of the CNDs (red and blue versus yellow bars) does not change the results, which demonstrates that it is not the CNDs which are detected here with DLS, which is due to their tiny size. Hydrodynamic radii rh = dh 2–1 of the CNDs were instead measured with fluorescence correlation spectroscopy (FCS, see the respective section in “Methods”), where only the CNDs and CND−protein complexes, but not the free proteins provide signal.

Protein adsorption on CNDs

To explore whether the chiral surface of CNDs has an impact on protein adsorption, the interaction of the CNDs with different proteins, human serum albumin (HSA, CAS No. 70024-90-7, Sigma Aldrich, Germany), transferrin human (Tf, CAS No. 11096-37-0, Sigma-Aldrich, Germany), and alpha-2-macroglobulin (α2M, SRP6314, Sigma-Aldrich, Germany) was investigated with fluorescence correlation spectroscopy (FCS)3941,6165. Measurements were carried out in a Confocal Light Scanning Microscope (CLSM) (LSM 880, Zeiss, Germany) with a Zeiss PlaN-Apochromat ×40/1.0 Water DIC (WD: 2.5 mm) objective with integrated FCS set-up (Zeiss). FCS studies were conducted with two solvents either in filtered Milli-Q water or in phosphate-buffered saline (PBS, Gibco, Invitrogen, Belgium). For measurements, proteins at different concentration were mixed with CNDs in either PBS or water, leading to a final variable protein concentration cP (P = HSA, Tf, α2M) and a fixed CND concentration CCND = 10 µg mL–1 for batch #1 and 50 µg mL–1 for batch #2 and batch #3. Before measurements all samples were incubated for 15 min and were then loaded to 35 mm petri dishes with glass bottom (Cat.No: 81218-200, ibidi GmbH, Germany) and were immediately covered by a cover glass (Product Code.10474379, Carl Zeiss™, Germany) with a thickness of 0.17 mm ± 0.005 mm. Subsequently, the lid of the glass bottle dish was assembled before FCS measurement. It is worth to mention, that the glass petri dish and the cover slide were continuously used through all measurements to exclude any possible deviation from their thickness, which could have probably resulted in an experimental error (the parameters ω0 and S of the excitation volume as described below might vary). To make sure that the glass petri dish and cover slide were sufficiently clean and dried before carrying out the next measurement, they were washed by ethanol and Milli-Q water successively, gently wiped with soft tissue paper and dried thoroughly under room temperature (RT) for 5 min. The FCS set-up had to be calibrated. Before carrying out the measurements, the focal volume was calibrated at 488 nm laser excitation with the laser power of 0.5 (at the Zeiss LSM set-up) using a dye with a known diffusion coefficient DRho = 414 ± 1 µm2 s–1 (Rhodamine 6G)66. Experimentally FCS determines diffusion times τD from an autocorrelation function G(τ) based on the fluorescence fluctuation of dyes diffusion in and out into the focus of the excitation. Here fluorescence fluctuations were recorded with 100 repetitions of each 10 s. An example of the autocorrelation function as obtained with Rhodamine 6G dissolved in water (cRho = 10 nM) is shown in Supplementary Fig. 34. This autocorrelation function was fitted with the following equation, using the FCS module implemented in the Zeiss ZEN software:

Gτ=1N1+T1Teτ/τTi=1Mfi1+τ/τDi11+τ/τDiS2 1

N is the average number of fluorophores within the effective detection volume, i.e. the volume of the excitation focus. M is the number of different fluorescent components in solution (e.g. if a mix of different fluorophores would be analyzed). In the present case M = 1, as there is either only Rhodamine 6G, or afterwards just CNDs in solution. fi determines the contribution of the different fluorescent components to the autocorrelation function. As here there is only one component f1 = 1. T is the fraction of the fluorescence decay from the triplet state of the fluorescent compound, and τT is the lifetime of the triplet state. For the Rhodamine 6G data shown in Supplementary Fig. 34 the mean of the fit parameters from three measurements were N = 0.15 ± 0.01, S = 4 ± 1, and τD = τRho = 22.5 ± 0.5. For the CNDs, the contribution of fluorescence from the triplet state was neglected, i.e. T = 0 and τT = ∞. The cross-section of the excitation volume is considered as ellipsoid and S is the ratio of the axis of this ellipsoid (for a sphere it would be S = 1). Thus, the effectively applied fit-function reduced to:

Gτ=1N11+τ/τD11+τ/τDS2 2

By assuming the excitation volume as ellipsoid (Gaussian ellipsoid approximation), the diffusion time τD related to the corresponding diffusion coefficient D via the width of the excitation volume ω0 by:

τD=ω024D 3

Using the experimentally determined value of the diffusion time τRho of Rhodamine 6G and the literature value of its diffusion constant DRho, the width of the excitation volume was calculated to be:

ω0=4DRhoτRho=0.193μm 4

By knowing ω0 as determined for the applied experimental conditions, measured diffusion times τD could be related to diffusion constants D, also for the CNDs. In the following these measurements were applied to the different CND samples (different CNDs with different protein concentrations) and for each data point three independent measurements were carried out. In Supplementary Fig. 35 the data for S-CNDs (batch #1) as exposed to different concentrations of HSA in PBS are presented. The corresponding diffusion times τD and diffusion coefficients D as determined from the fit as provided in Supplementary Table 11. From the diffusion coefficients D the corresponding hydrodynamic radii were calculated according to the StokesEinstein equation:

rh=kBT6πηD 5

kB = 1.38 × 10−23 J K–1 is the Boltzmann constant, T = 298.15 K room temperature, and η is the solution viscosity. The solution viscosity was assumed to depend linearly on the protein concentration according to:

η=η0ηiCP+1 6

The protein mass concentration CP relates to the molar protein concentration cP by the molar mass of the protein MW(P). η0 = 0.89 mPa × s is the viscosity of PBS, which is assumed to be the viscosity of water (at room temperature). ηi is the intrinsic viscosity of the proteins. Hereby the following values were used: HSA: MW(HSA) = 66.5 kDa, ηi = 4.2 cm3 g–1; Tf: MW(Tf) = 80 kDa, ηi = 4.4 cm3 g–1; α2M: MW(α2M) = 725 kDa40. In Supplementary Table 11 the conversion of diffusion coefficients D into hydrodynamic radii rh is demonstrated. The resulting hydrodynamic radii rh versus protein concentrations cP are listed of the different types and batches of CNDs as recorded in water in Supplementary Fig. 36 and as recorded in PBS in Supplementary Fig. 10. In the following, all further discussion will be based on the results obtained in PBS. The data recorded in PBS with HSA show a saturation of the hydrodynamic radius, e.g. at high protein concentration the CND surface is completely saturated with proteins and thus the hydrodynamic radius does not increase further with raising concentrations. The behavior can be fitted with the Hill model39. For this, the rh(cHSA) curves shown in Supplementary Fig. 10 were fitted with the following equation:

rhcHSA=rh01+VHSAVCNDNmax11+KDcHSAn3 7

VHSA is the volume of one HSA molecule. Assuming a triangular prism shape with 8.4 nm side length and 3.2 nm height we used VHSA = 96 nm3 39. VCND is the volume of one CND, considering the CNDs as spheres, and the radius rh(0) obtained from the FCS of the control sample, no protein:

VHSA=43πrh03 8

rh(0) is an experimentally determined value and is enlisted in Supplementary Table 5. The fit function had the following free fit parameters: rh,0, Nmax, KD, and n. rh,0 is the value from the fit for the hydrodynamic radius of the CNDs with no adsorbed proteins, i.e. rh(cHSA ≪ KD). rh,0 is a fit parameter, rh(0) is an experimentally determined value. Nmax is the number of HSA molecules bound per CND in saturation (i.e. cHSA ≫ KD), KD is the dissociation coefficient, and n is the Hill coefficient39. The resulting fit values from the curves shown in Supplementary Fig. 10 are presented in Supplementary Table 5.

Cell culture techniques

Two cell lines were used in this study: THP-1 monocytes and HeLa cells. The human monocytic leukemia cell line THP-1 (ATCC® TIB-202™) was obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). THP-1 cells were cultured in suspension in RPMI 1640 medium (Sigma-Aldrich, #61870010) containing 10% heat inactivated fetal bovine serum (FBS, Biochrom, UK), 1 mM sodium pyruvate (Sigma-Aldrich, #S8636), 0.05 mM β-mercaptoethanol (Sigma-Aldrich, #M3148), 100 U mL–1 penicillin and 100 μg mL–1 streptomycin (P/S, Sigma-Aldrich, Germany) in a humidified incubator at 37 °C and 5% CO2. For experimental usage, Phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich, #P1585) was applied to the THP-1 monocyte (cell passage less than 30) with a dosage of 150 nM14 for 3 days, inducing the differentiation from THP-1 monocytes to THP-1 macrophages. After stimulation, the THP-1 macrophages were exposed to the CNDs for in vitro uptake, toxicity, and colocalization studies (Supplementary Fig. 37). The human cervix cell line HeLa cells were purchased from ATCC and maintained in Dulbecco’s modified Eagle’s medium (DMEM, Thermofisher, USA) supplemented with 10% fetal bovine serum (FBS, Biochrom, Germany) and 100 U mL–1 penicillin/streptomycin (P/S, Fisher Scientific, Germany) at 37 °C and 5% CO2, until desired confluence was reached, before adding the CNDs.

Cell viability assays

The cell viability of THP-1 derived macrophages and HeLa cells after exposure to CNDs was evaluated by the resazurin assay50,67. In viable cells there is a metabolic reduction of the non-fluorescent resazurin to the highly fluorescence of resorufin, and thus this fluorescence is assumed to be proportional to the number of living cells. In case of the addition of toxic materials the number of living cells will be decreased. As cell viability V the percentage of living cells in reference to a sample with untreated control cells is defined50. Before evaluating the biocompatibility of the CNDs, several tests were performed to exclude the possibility that the fluorescent CNDs would interfere with the resazurin assay. In a first step, we investigated possible interference effects of CNDs with resazurin (i.e. without exposing the CNDs to cells), analyzing the concern that the CNDs alone could trigger the conversion of resazurin to resorufin. Briefly, several solutions were prepared as follows, including H2O, RPMI 1640 medium supplemented with 10% FBS, 0.025 mg mL–1 resazurin solution in RPMI 1640 medium with 10% FBS, CCND = 200 μg mL–1 of R-CNDs or S-CNDs in H2O, CCND = 200 μg mL–1 of R-CNDs or S-CNDs in 10% FBS supplemented RPMI 1640 medium containing 0.025 mg mL–1 resazurin (Sigma Aldrich, USA). Then 100 μL of each solution was loaded to a 96-well plate (Sarstedt, Germany) with 0.34 cm2 growth area per well and the fluorescence spectra of each well was collected from 570 to 620 nm by a fluorimeter (Fluorolog-3, Horiba Jobin Yvon, USA) with excitation at 560 nm (Supplementary Fig. 38). Data show that the addition of CNDs to resazurin did not trigger fluorescence (i.e. conversion of resazurin to resorufin). In a second step, we investigated the interference effect of the fluorescence of the CNDs, which might interfere with the fluorescence of resorufin. THP-1 monocytes were seeded at a density of 34,000 cells/well with the medium volume Vmedium = 0.136 mL per well in a 96-well plate with 0.34 cm2 growth area per well and were differentiated to macrophages within in 3 days (Supplementary Fig. 37). Afterwards, the supernatant was removed and 100 μL of R-, S- or N-CNDs (CCND = 200 μg mL–1) diluted in RPMI 1640 medium containing 10% FBS were added to the THP-1 derived macrophages. As control cells were exposed to medium without added CNDs. Cells were further incubated for 24 h in a humidified incubator at 37 °C, 5% CO2. The next day, resazurin salt solution (Sigma Aldrich, USA) at a concentration of 0.25 mg mL–1 was mixed with 10% FBS supplemented RPMI 1640 medium at a volume ratio of 1:10 as resazurin working solution. The control cells which had not been exposed to CNDs, the cells in each well were washed with 100 μL of phosphate-buffered saline (PBS, Gibco, Invitrogen, Belgium) and 100 μL of resazurin working solution was added. The CND-treated cells remained unchanged. Cells were further incubated at 37 °C and 5% CO2 for 4 h. After this the fluorescence spectra of the different wells were collected from 570 to 620 nm at 560 nm excitation by a fluorimeter (Fluorolog-3, Horiba Jobin Yvon, USA; Supplementary Fig. 38b). As shown in Supplementary Fig. 38b, the significant fluorescence of resorufin from cells which have been treated with resazurin. The fluorescence from cells which had been treated with only CNDs was negligible in comparison to the resorufin fluorescence. This rules out interference of the viability test with the intrinsic CND fluorescence. For the viability tests slightly different protocol were used for the THP-1 monocytes and the HeLa cells. The THP-1 monocytes were seeded at a density of 34,000 cells/well with the medium volume Vmedium = 0.136 mL per well in a 96-well plate with 0.34 cm2 growth area and were differentiated to macrophages. On the fourth day, the supernatant in each well was removed and then CND solution (i.e. CNDs dispersed in medium with or without FBS supplement; Vmedium = 0.136 mL) with a series of different concentrations was added for 24 or 48 h. In contrast, HeLa cells were seeded in 96-well plates with 0.34 cm2 growth area at a density of 7500 cells/well in 0.1 mL DMEM medium supplemented with 10% FBS. On the following day, the old medium was removed then CND solution (Vmedium = 0.1 mL; with or without FBS supplement) with a series of different concentrations was added for 24 or 48 h. For both cell lines, after the incubation time, phosphate-buffered saline (PBS, Gibco, Invitrogen, Belgium) (VPBS = 0.1 mL) was used to wash the cells once, then 100 μL of resazurin working solution was added and further incubated for 4 h at 37 °C. The resazurin working solution was prepared by diluting the resazurin salt solution (Sigma Aldrich, USA) at a concentration of 0.25 mg mL–1 ten times with 10% FBS supplemented medium (RPMI 1640 in case of THP-1 derived macrophages and DMEM in the case of HeLa cells). Afterwards, the fluorescence spectra of each well were collected from 570 to 620 nm with an excitation of 560 nm as described above. Subsequently, Matlab software was used for data analysis based on the fluorescence intensity at 590 nm, which was considered proportional to the number of living cells. The viability V represent the fluorescence intensity of cells treated with CNDs normalized to the fluorescence intensity of untreated control cells. All experimental conditions were recorded from triplicate independent experiments. As shown in Supplementary Figs. 39 and 40, both cell lines maintained high viability at different exposure doses of CNDs ranging from CCND 0.488 µg mL–1 to 1000 µg mL–1 for the different incubation times (24 and 48 h) in cell culture medium supplemented with or without 10% FBS. These results are consistent with the other biocompatibility tests regarding CNDs68.

Time- and dose-dependent uptake studies based on flow cytometry

Time-dependent uptake of CNDs by HeLa cells

Uptake of the different CNDs by HeLa cells was investigated. Firstly, HeLa cells were seeded at a density of 40,000 cells well–1 with 10% FBS contained DMEM medium of volume Vmedium = 1 mL per well in 24-well plates (Sartstedt, Germany) with 1.9 cm2 seeding area per well. On the next day, the medium in each well was removed and then CNDs diluted in DMEM medium supplemented with 10% or 0% FBS (Vmedium = 0.5 mL) were added to the HeLa cells for specific time points (1, 3, 6, 24 or 48 h) at a concentration of CCNDs = 400 µg mL–1. After the exposure time, cells were washed three times with 0.5 mL cold PBS, detached by addition of 0.05% trypsin-EDTA, isolated by centrifugation at 300 × g for 5 min, and finally re-suspended in 0.3 mL cold PBS for flow cytometer analysis (BD LSRFortessa™, BD Biosciences, US). The CND fluorescence signal I within each cell was collected with the flow cytometer with a 450/50 nm bandpass filter upon 405 nm excitation. 10,000 gated cells were counted and analyzed for each sample. Then, the Flowjo software was used to analyze the flow cytometry data. The recorded mean CND fluorescence per cell I was then background-corrected by subtracting the fluorescence of control cells which had not been exposed to CNDs, leading to the background-corrected mean CND fluorescence per cell:

I*I*CCNDs=ICCNDsICCNDs=0 9

Finally, as the different CNDs at the same concentration CCND have a different fluorescence the correction factor X as determined in Supplementary Table 4 was taken into account:

ICCNDs=I*CCNDsforSCNDs 10
ICCNDs=XS/RI*CCNDsforRCNDs 11
ICCNDs=XS/NI*CCNDsforNCNDs 12

These effective fluorescence intensities per cell I′ were the values which were further compared. In Supplementary Fig. 23 the raw data of the flow cytometry measurements are shown. In Supplementary Fig. 22 the mean fluorescence intensity per cell data as extracted from those raw data are plotted. As additional parameter also the percentage of HeLa cells which had endocytosed CNDs Pcell was calculated from the flow cytometer data (Supplementary Fig. 23) by the Flowjo software. Here a fluorescence threshold was set to distinguish cells with fluorescence from internalized CNDs from the autofluorescence of cells. The gating strategy is shown in Supplementary Fig. 41. The results from n = 3 experiments are displayed in Supplementary Fig. 42.

Time- and dose-dependent uptake of CNDs by THP-1 derived macrophages

Apart from HeLa cells we selected THP-1 derived macrophages as cell model. Macrophages are important cells of the immune system, capable of distinguishing pathogens such as bacteria, cellular debris and foreign entities69,70. Thus, they might be in particular sensitive concerning the surface properties of CNDs (such as different chirality of the CNDs) in regard of CND endocytosis. Briefly, THP-1 monocytes were seeded at a density of 100,000 cells/well with 10% FBS containing RPMI 1640 medium with volume Vmedium = 0.4 mL per well in 48-well plates (Sartstedt, Germany) with 1 cm2 growth area per well and they were differentiated into THP-1 derived macrophages within 3 days (see the respective section in “Methods”). Then, the supernatant was removed, and CND solution (Vmedium = 0.4 mL) was added to the THP-1 derived macrophages at final concentrations ranging from CCNDs = 50 µg mL–1 to 400 µg mL–1 for different time points t, including 1, 3, 6, 24 and 48 h in RPMI 1640 medium supplemented with 10% or 0% FBS. After the different incubation time points, cells were washed three times with 0.5 mL cold PBS, detached by 0.05% trypsin-EDTA solution (Thermofisher, USA), isolated by centrifugation at 300 × g for 5 min, and were then re-suspended in 220 μL cold PBS. Subsequently, the re-suspended cells were analyzed by flow cytometry in the same way as described in the respective section in “Methods” for the HeLa cells. In the same way background subtraction and adjustments for the different fluorescence intensities of the CNDs was performed. The results for different incubation concentrations CCNDs and incubation times are provided in Supplementary Figs. 25 and 43.

Time-dependent uptake studies based on confocal microscopy

Uptake of CNDs by THP-1 derived macrophages was also quantified by confocal laser scanning microscopy (CLSM; LSM 510, Zeiss, Germany) with a Plan-Apochromat ×63/1.40 Oil DIC M27 objective. THP-1 monocytes were seeded at a density of 75,000 cells per well in complete RPMI 1640 medium with the volume Vmedium = 0.3 mL per well in µ-Slide 8 Wells (ibidi GmbH, Germany) with 1 cm2 growth area per well, and were differentiated into THP-1 derived macrophages within 3 days (see the respective section in “Methods”). On the fourth day, the medium was removed, and CND solution (Vmedium = 0.3 mL) was added to cells at a concentration of CCNDs = 400 μg mL–1 in RPMI 1640 medium supplemented with 10% or 0% FBS subsequently. At specific time points t similar to those chosen for flow cytometry experiments (see the respective section in “Methods”), cells were imaged by CLSM using a 405 nm laser as the excitation source and a LP 420 nm long pass filter for recording the fluorescence emission. Representative images are shown in Supplementary Figs. 52 and 53. After obtaining the CLSM images at each time point, quantitative analysis of cellular CND uptake was performed by utilizing a combination of free open-source software. In a first step, the images as obtained from the Zeiss microscope software were converted to TIFF format utilizing Matlab software. In a second step, Adobe photoshop CS6 was used to manually denote the perimeter of the cells. In a third step, the sum of the fluorescence intensities of all pixels belonging to a cell was calculated by the image analysis software Cellprofiler v2.2.0, and converted to the mean fluorescence per cell by dividing the summed up pixel intensities by the number of fluorescent cells54,71. The intensity values were then corrected by the fluorescence difference between the different CND sample according to Supplementary Table 4:

ICCNDs=I*CCNDsforSCNDs 13
ICCNDs=XS/RICCNDsforRCNDs 14
ICCNDs=XS/NICCNDsforNCNDs 15

More than 200 cells in at least 20 images from three independent experiments were analyzed for each time point (n = 3). No background correction was performed, as the background fluorescence was low. The results are shown in Supplementary Fig. 12 and Supplementary Table 8. In addition, from the microscopy data exemplary shown in Supplementary Figs. 52 and 53 the percentage Pcell of cells which had internalized CNDs was determined. Data are shown in Supplementary Fig. 54. This counting was performed manually, which was possible due to the low background. To achieve a low background first a control cell which had not been exposed to CNDs was imaged and the parameters of the confocal microscope (e.g. laser power and pinhole) were adjusted in a way that no fluorescence could be observed by the naked eye in the fluorescence images. With these settings then the cells with internalized CNDs were recorded.

Colocalization of CNDs with intracellular organelles

Colocalization studies of mitochondria or lysosome and CNDs

Colocalization studies of internalized CNDs with cell organelles, i.e. mitochondria and lysosomes, were carried out for THP-1 derived macrophages and for HeLa cells using Confocal Laser Scanning Microscopy (CLSM) (LSM 510, Zeiss, Germany) with a Plan-Apochromat ×63/1.40 Oil DIC M27 objective. Firstly, THP-1 monocytes were seeded at a density of 75,000 cells per well with complete RPMI 1640 medium volume Vmedium = 0.3 mL supplemented with PMA at a concentration of 150 nM in µ-Slide 8 Wells (ibidi GmbH, Germany) with 1 cm2 growth area per well. After 72 h incubation time in a cell culture incubator, the THP-1 monocytes had been differentiated into THP-1 derived macrophages. In the case of HeLa cells, 12,000 cells were seeded per µ-Slide 8 Well with the complete DMEM medium of volume Vmedium = 0.3 mL per well and were cultured in a cell culture incubator at 37 °C in 5% CO2 overnight. After this, for both cells type the previous medium was replaced with the Vmedium = 0.3 mL CNDs dispersed in RPMI 1640 and DMEM medium supplemented with 10% or 0% FBS at a concentration of CCNDs = 400 μg mL–1 for THP-1 derived macrophages and HeLa cells, respectively. After 24 or 48 h incubation time, mitochondria and lysosome were labeled with corresponding staining reagents as described in the following.

Immunostaining procedures

For mitochondrial staining, MitoTrackerR Deep RedFM (Catalog No.: M22426, ThermoFisher Scientific)72 was used to specifically label the mitochondria. Briefly, cells were washed three times with 200 μL PBS and then 200 μL of pre-warmed (37 °C) MitoTrackerR Deep RedFM in complete RPMI 1640 medium at a concentration of 400 nM was added and cells were further incubated in the incubator for 30 min at 37 °C. Afterwards, the staining solution was replaced with fresh pre-warmed RPMI 1640 medium without phenol red (Catalog No.: 11835030, ThermoFisher Scientific) and cells were observed using CLSM. A laser diode emitting at 405 nm and a bandpass emission filter BP 420–480 nm were used to visualize the CNDs. A helium–neon laser of 633 nm and long pass filter LP 650 nm were used for recording the fluorescence of MitoTrackerR Deep RedFM. For lysosome staining, LysoTracker™ Green DND-26 (Catalog No: L7526, ThermoFisher Scientific) was selected as the lysosomal marker7375. Firstly, cells were washed three times with 200 μL PBS. Subsequently, 200 μL of pre-warmed (37 °C) LysoTracker™ Green DND-26 at a concentration of 1 μM in complete RPMI 1640 medium was added and cells were further incubated at 37 °C in 5% CO2 for 30 min prior to imaging with CLSM. The excitation laser and emission collection setups were the same for the CNDs as that used in the colocalization studies of mitochondria and CNDs. An argon laser of 488 nm together with the BP 505–530 nm bandpass filter were used for observing the fluorescence of LysoTracker™ Green DND-26.

Calculation of Manders’ coefficients from the colocalization data

Based on the CLSM images, colocalization was quantified by quantitatively calculating Manders’ coefficients m1 and m2, which are indicators of the overlap degree between pixels from two different fluorescence channels ranging from 0 to 1 73,76,77. To achieve this purpose, Matlab and Cellprofiler v2.2.0 were used to calculate Manders’ coefficients54,77,78. Briefly, the Matlab software was firstly used to subtract the background from the 8-bit grayscale TIFF images. Secondly, Cellprofiler v2.2.0 was used to identify pixels belonging to cells. Then the colocalization of CNDs and mitochondria or lysosomes for all pixels corresponding to cells was calculated. Thirdly, the below given equations were used to calculate Manders’ coefficients using Matlab. Hereby m1 is the percentage of blue fluorescent pixels (i.e. CNDs) that overlapped with red or green fluorescent pixels (i.e. mitochondria or lysosomes). m2 is the percentage of red or green fluorescent pixels (i.e. mitochondria or lysosomes) which overlap with blue fluorescent pixels (i.e. CNDs).

m1=iI(B)i,colociI(B)i 16
m2=iI(R)i,colociI(R)iorm2=iI(G)i,colociI(G)i 17

Hereby i = 1… N denotes all N pixels which belong to cells. I(B)i, I(R)i, and I(G)i are the fluorescence intensities I at pixel i as obtained from the blue, red, and green channels of the fluorescence images. I(B)i,coloc, I(R)i,coloc, and I(G)i,coloc are the fluorescence intensities I from the blue, red, and green channel only for pixels i where there is also green/red, blue, and blue fluorescence. m1 or m2 = 0 represents no overlap, while 1 denotes complete overlap of the fluorescence channels. As expected, the CNDs were largely localized inside lysosomes, and did not co-locate to a large amount with mitochondria. Selected fluorescence images and the resulting Manders’ coefficient calculations are shown in Supplementary Figs. 15 and 5666.

Studies about the uptake pathway

Distinguishing CNDs adherent to the cell membrane from endocytosed CNDs

Flow cytometry based on standard fluorophores cannot distinguish trivially between CNDs adherent only on the outer cell membrane from actually endocytosed CNDs79. Both scenarios however can be distinguished using confocal microscopy. To confirm that the majority of fluorescence signal from CNDs associated with cells originates from internalized CNDs z-stacks were recorded80 with CLSM (LSM 510, Zeiss, Germany) with a PlaN-Apochromat ×63/1.40 Oil DIC M27 objective. Herein, Calcein-AM (Molecular Probes) was applied to label living cells (i.e. cells with esterase activity)50, through enzymatic transformation from the non-fluorescent calcein AM to the highly fluorescent calcein81. Esterase activity only happens inside cells, and thus is a good label for the volume of the cell. In case the blue fluorescence CNDs overlapped with the green calcein AM fluorescence they can be considered internalized. The experiment was performed in the following way. On the first day, THP-1 monocytes were seeded at a density of 75,000 cells per well with complete RPMI 1640 medium (Vmedium = 0.3 mL) in µ-Slide 8 Wells with 1 cm2 growth area per well and were differentiated into THP-1 derived macrophages for 3 days. Then, the supernatant was removed and afterwards the CND (Vmedium = 0.3 mL) dispersed in RPMI 1640 medium with or without serum were added to cells at a concentration of CCNDs = 400 μg mL–1 for 24 h. Afterwards, cells were washed three times with PBS (200 μL each) followed by adding 200 μL pre-warmed (37 °C) Calcein AM (one component of the LIVE/DEAD™ Viability/Cytotoxicity Kit, Catalog No: L3224, Thermofisher Scientific) diluted in complete RPMI 1640 medium at a concentration of 1.3 μM. The cells were further incubated with the calcein staining solution at 37 °C for 30 min. Afterwards, the cells were washed with 200 μL PBS once and 300 μL of fresh pre-warmed RPMI medium without phenol red was added prior to imaging by confocal microscopy using z-stack analysis (Supplementary Figs. 67 and 68)80. A laser diode emitting at 405 nm and a bandpass emission filter BP 420–480 nm were used for the excitation and emission collection of CNDs. An argon laser of 488 nm together with a bandpass emission filter BP 505–550 nm were used to visualize the fluorescence of calcein. In Supplementary Figs. 67 and 68, cross-sections through cells as indicated by the red and green solid lines are shown. These data clearly show that the blue fluorescence emitted from the CNDs originates from inside the cells, and thus corresponds to endocytosed CNDs.

Uptake of CNDs by THP-1 derived macrophages under the presence of inhibitors

The endocytosis pathway of CNDs can be investigated by evaluating the inhibition of certain internalization pathways by pharmacological/chemical inhibitors associated with82. In our case, we investigated the cellular uptake pathway of CNDs using the following chemical inhibitors: (i) Nocodazole83 (an inhibitor of endocytosis of lager nanoparticles82,84,85, CAS No.31430-18-9, Sigma-Aldrich, Germany), (ii) Bafilomycin A184 (an inhibitor of phagocytosis86,87, CAS No. 88899-55-2, InvivoGen, France), (iii) Amiloride88 (an inhibitor of micropinocytosis89,90, CAS No. 17440-83-4, Sigma-Aldrich, Germany), and (iv) Chlorpromazine88 (an inhibitor of clathrin-associated endocytosis89,91, CAS No.69-09-0, Sigma-Aldrich, Germany). While the inhibitors were applied, still cytotoxicity experiments for the above inhibitors were carried out to ensure that at the used concentrations the inhibitors are not toxic. For experiments on the first day, THP-1 monocytes were seeded at a density of 34,000 cells per well with complete RPMI 1640 medium (Vmedium = 0.136 mL) in 96-well plates with 0.34 cm2 growth area per well and were differentiated into THP-1 derived macrophages. On the fourth day, the supernatant was removed and then each inhibitor diluted in RPMI 1640 medium supplemented with 10% or 0% FBS at several concentrations was added to the cells for 7 or 25 h. The exposure concentrations of each inhibitor are summarized in Supplementary Table 16. After the incubation time of 7 h or 25 h, the cell viability test was performed following the protocols described in the respective section in “Methods”. As shown in Supplementary Fig. 69, the four chemical inhibitors were non-toxic to THP-1 derived macrophages at the used concentration ranges. To ensure that there is also not reduction of cell viability of the THP-1-derived macrophages after exposing to CNDs pre-incubated with the cellular uptake inhibitors, also for this scenario a viability assay was carried out. Briefly, THP-1 monocytes were differentiated into THP-1 derived macrophages with an original seeding density of 34,000 cells per well with complete RPMI 1640 medium volume (Vmedium = 0.136 mL) in 96-well plates. After 3 days, the previous medium was substituted with 0.136 mL of fresh RPMI 1640 medium containing 10% or 0% FBS containing optionally Nocodazole, Bafilomycin A1, Amiloride, or Chlorpromazine. The concentrations used for each inhibitor are described in Supplementary Table 17. Afterwards, cells treated with the inhibitors were incubated at 37 °C. Cells cultured at 37 °C without exposure to inhibitors were used as positive controls. Cells cultured at 4 °C (i.e. conditions where there is reduced endocytosis) without exposure to inhibitors were used as negative controls. After 1 h incubation time, the three types of CNDs were directly added at a final concentration of CCNDs = 400 μg mL–1 and the 96-well plates were further incubated at the original conditions for another 6 h before the viability measurements. As shown in Supplementary Figs. 70 and 71, the exposure of the above inhibitors together with the CNDs did not reduce viability of the THP-1 derived macrophages. Thereafter, the cellular uptake pathway of CNDs in THP-1 derived macrophages was investigated. The experiment was conducted as follows. On the first day, THP-1 monocytes were seeded at a density of 100,000 cells per well with 10% FBS containing RPMI 1640 medium (Vmedium = 0.4 mL) in 48-well plates (Sartstedt, Germany) with 1 cm2 growth area per well. After 3 days, the cells were differentiated into THP-1 derived macrophages. Afterwards, the previous cell culture medium was replaced with fresh RPMI 1640 medium containing 10% or 0% FBS, supplemented optionally with Nocodazole, Bafilomycin A1, Amiloride, or Chlorpromazine at the concentrations described in Supplementary Table 17. The cells treated with the inhibitors were cultured at 37 °C for 1 h. Cells without exposure to inhibitors were cultured at 37 °C as positive controls. Cells without exposure to inhibitors were cultured at 4 °C (i.e. there is reduced endocytosis) as negative control. After the incubation time, the three types of CNDs were directly added at a final concentration of 400 μg mL–1 and the plates were further incubated at the original conditions for another 6 h before flow cytometry analysis. The sample collection procedure, flow cytometry setups, and data analysis methods were the same as described in the respective section in “Methods”. As shown in Supplementary Figs. 72 and 73, the cellular uptake of the CNDs was blocked at 4 °C, suggesting that the internalization of the CNDs is an energy-dependent process55. Presence of Bafilomycin A1 drastically reduced the uptake of CNDs. Thus, phagocytosis will be a major route of uptake of the CNDs86,87. In case of the N-CNDs also presence of Chlorpromazine reduced uptake of the CNDs. Thus here also clathrin-associated endocytosis will be a relevant uptake pathway for N-CNDs89,91. We point out again that the N-CNDs were partially agglomerated, which might be the reason for this additional pathway, which is most likely not related to the chirality of the CNDs. Addition of nocodazole did not reduce CND uptake, which is understandable as this has been reported to block in particular uptake of larger particles84,85. Amiloride caused autofluorescence in the cells, which is why under presence of this inhibitor there is elevated fluorescence also in the presence of CNDs, which however is autofluorescence of the inhibitor.

Uptake of CNDs by Hela cells under the presence of inhibitors

The same experiments as done with THP-1 derived macrophages were also carried out for Hela cells. First, the cytotoxicity of CNDs pre-incubated with cellular uptake inhibitors was conducted. For that, 7500 HeLa cells in 0.1 mL complete DMEM medium were seeded in 96-well plates with a growth area of 0.34 cm2 per well at 37 °C overnight. Afterwards, the old medium was removed and HeLa cells were incubated with fresh DMEM medium containing 10% or 0% FBS without or with inhibitors at the concentrations enlisted in Supplementary Table 17. Then, the inhibitor treated cells were incubated at 37 °C. As positive control cells without presence of inhibitors were used. As negative control cells without exposure to inhibitor were cultured at 4 °C instead at 37 °C. After 1 h incubation, the three types of CNDs were added to the cells at a final concentration of CCNDs = 400 μg mL–1 (i.e. the inhibitors were not removed) and the plates were furtherly cultured at the original conditions (37 °C or 4 °C for the negative control) for another 6 h. Then the resazurin assay was applied. The results shown in Supplementary Figs. 74 and 75 demonstrated that the CNDs and chemical cellular uptake inhibitors did nor reduce the viability of the HeLa cells. In order to analyze the effect of the different inhibitors on the uptake of CNDs by Hela cells the same strategy as for the THP-1 derived macrophages was used. Briefly, 40,000 HeLa cells in 1.0 mL 10% or 0% FBS containing DMEM medium were seeded into 24-well plates with 1.9 cm2 growth area per well at 37 °C overnight. On the following day, the medium was substituted with fresh DMEM medium supplemented with 10% or 0% serum without or with cellular uptake inhibitors at desired concentrations (Supplementary Table 17). The cells treated with inhibitors (or as positive control without inhibitors) were incubated at 37 °C for 1 h. As negative control cell which have not been treated with inhibitor were cultured at 4 °C for 1 h. After this incubation interval, the three types of CNDs were added to the cells (without removing the medium with the inhibitors) at a final concentration of CCNDs = 400 μg mL–1. Then the plates were returned back with the original incubation conditions (37 °C or 4 °C for the negative control) for another 6 h before sample collection for flow cytometry analysis. The sample collection, flow cytometry setups and data analysis approach were used as described in the respective section in “Methods”. Note that here no correction for the different fluorescence emissions of the different types of CNDs was carried out, i.e. I and not I′ is plotted. As can be seen in Supplementary Figs. 76 and 77 incubation at 4 °C blocked CND uptake by cells, indicating that endocytosis of the CNDs is an energy consumed process. Besides, the three types of CNDs were taken up by the HeLa cells largely via a phagocytosis pathway, while N-CNDs could also be endocytosed by the HeLa cells via a clathrin-associated endocytosis pathway, similar to the results obtained for the THP-1 derived macrophages.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Supplementary information

Supplementary Information (21.6MB, docx)
Peer Review File (5.6MB, pdf)
Reporting Summary (367.5KB, pdf)

Acknowledgements

H.Y. and S.M. had fellowships from Chinese Scholarship Council (CSC) and Deutscher Akademischer Austauschdienst (DAAD), respectively. This project was funded by the Cluster of Excellence ‘Advanced Imaging of Matter’ of the Deutsche Forschungsgemeinschaft (DFG)—EXC 2056—project ID 390715994. Further support was received from the University of Trieste, INSTM, AXA Research Fund, the Spanish Ministry of Science, Innovation and Universities, MICIU (project PID2019-108523RB-I00), the Italian Ministry of Education MIUR (cofin Prot. 2017PBXPN4), the Maria de Maeztu Units of Excellence Program from the Spanish State Research Agency (MDM‐2017‐0720), and the European Research Council (Advanced Grant agreement 885323). Parts of this work were supported by Fraunhofer Attract (Fraunhofer-Gesellschaft).

Author contributions

H.Y. and M.C. designed and performed the experiments. M.P., W.J.P. and N.F. conceived and coordinated the project. W.J.P. wrote the manuscript with input from all the authors. L.Ð., F.A. and D.Z. oversaw the research and contributed to the experimental design. S.M. contributed with the FCS measurements. F.S. contributed with the TEM and NTA analyses. M.P., W.J.P. and N.F. oversaw the research and secured the funding.

Peer review information

Nature Communications thanks Xiaoyuan Chen and the other anonymous reviewers for their contribution to the peer review of this work. Peer reviewer reports are available.

Data availability

The data supporting the findings of this study are either provided in the article and its Supplementary Information or available from the corresponding authors upon request.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Huijie Yan, Michele Cacioppo.

Contributor Information

Maurizio Prato, Email: mprato@cicbiomagune.es.

Wolfgang J. Parak, Email: wolfgang.parak@uni-hamburg.de

Neus Feliu, Email: neus.feliu@physnet.uni-hamburg.de.

Supplementary information

The online version contains supplementary material available at 10.1038/s41467-021-27406-1.

References

  • 1.Brooks WH, Guida WC, Daniel KG. The significance of chirality in drug design and development. Curr. Top. Med. Chem. 2011;11:760–770. doi: 10.2174/156802611795165098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Caner H, Groner E, Levy L, Agranat I. Trends in the development of chiral drugs. Drug Discov. Today. 2004;9:105–110. doi: 10.1016/s1359-6446(03)02904-0. [DOI] [PubMed] [Google Scholar]
  • 3.Hutt AJ, Tan SC. Drug chirality and its clinical significance. Drugs. 1996;52:1–12. doi: 10.2165/00003495-199600525-00003. [DOI] [PubMed] [Google Scholar]
  • 4.Yuan L, et al. Chiral polymer modified nanoparticles selectively induce autophagy of cancer cells for tumor ablation. J. Nanobiotechnol. 2018;16:55. doi: 10.1186/s12951-018-0383-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Smith SW. Chiral toxicology: it’s the same thing… only different. Toxicol. Sci. 2009;110:4–30. doi: 10.1093/toxsci/kfp097. [DOI] [PubMed] [Google Scholar]
  • 6.Nguyen LA, He H, Pham-Huy C. Chiral drugs: an overview. Int. J. Biomed. Sci. 2006;2:85–100. [PMC free article] [PubMed] [Google Scholar]
  • 7.De Fenza M, et al. Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease. Eur. J. Med. Chem. 2019;175:63–71. doi: 10.1016/j.ejmech.2019.04.061. [DOI] [PubMed] [Google Scholar]
  • 8.Ma W, et al. Chiral inorganic nanostructures. Chem. Rev. 2017;117:8041–8093. doi: 10.1021/acs.chemrev.6b00755. [DOI] [PubMed] [Google Scholar]
  • 9.Suzuki N, et al. Chiral graphene quantum dots. ACS Nano. 2016;10:1744–1755. doi: 10.1021/acsnano.5b06369. [DOI] [PubMed] [Google Scholar]
  • 10.Sun M, et al. Intracellular localization of nanoparticle dimers by chirality reversal. Nat. Commun. 2017;8:1847. doi: 10.1038/s41467-017-01337-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gao X, Han B, Yang X, Tang Z. Perspective of chiral colloidal semiconductor nanocrystals: opportunity and challenge. J. Am. Chem. Soc. 2019;141:13700–13707. doi: 10.1021/jacs.9b05973. [DOI] [PubMed] [Google Scholar]
  • 12.Zhao X, Zang S-Q, Chen X. Stereospecific interactions between chiral inorganic nanomaterials and biological systems. Chem. Soc. Rev. 2020;49:2481–2503. doi: 10.1039/d0cs00093k. [DOI] [PubMed] [Google Scholar]
  • 13.Zafar MS, Ragusa A. Chirality at the nanoparticle surface: functionalization and applications. Appl. Sci. 2020;10:5357. [Google Scholar]
  • 14.Zhao X, et al. Tuning the interactions between chiral plasmonic films and living cells. Nat. Commun. 2017;8:2007. doi: 10.1038/s41467-017-02268-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tang H, Li Q, Yan W, Jiang X. Reversing the chirality of surface ligands can improve the biosafety and pharmacokinetics of cationic gold nanoclusters. Angew. Chem. Int. Ed. 2021;60:13829–13834. doi: 10.1002/anie.202101609. [DOI] [PubMed] [Google Scholar]
  • 16.Lundqvist M, et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl Acad. Sci. USA. 2008;105:14265–14270. doi: 10.1073/pnas.0805135105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wang X, et al. Chiral surface of nanoparticles determines the orientation of adsorbed transferrin and its interaction with receptors. ACS Nano. 2017;11:4606–4616. doi: 10.1021/acsnano.7b00200. [DOI] [PubMed] [Google Scholar]
  • 18.Wang X, et al. Probing adsorption behaviors of BSA onto chiral surfaces of nanoparticles. Small. 2018;14:e1703982. doi: 10.1002/smll.201703982. [DOI] [PubMed] [Google Scholar]
  • 19.Deng J, Zheng H, Gao C. Influence of protein adsorption on the cellular uptake of AuNPs conjugated with chiral oligomers. Mater. Chem. Front. 2017;1:542–549. [Google Scholar]
  • 20.Srivatsan A, et al. Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a. Bioorgan. Med. Chem. 2015;23:3603–3617. doi: 10.1016/j.bmc.2015.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Deng J, Wu S, Yao M, Gao C. Surface-anchored poly(acryloyl-L(D)-valine) with enhanced chirality-selective effect on cellular uptake of gold nanoparticles. Sci. Rep. 2016;6:31595. doi: 10.1038/srep31595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Li Y, et al. Chirality of glutathione surface coating affects the cytotoxicity of quantum dots. Angew. Chem. Int. Ed. 2011;50:5860–5864. doi: 10.1002/anie.201008206. [DOI] [PubMed] [Google Scholar]
  • 23.Li F, et al. Highly fluorescent chiral N-S-doped carbon dots from cysteine: affecting cellular energy metabolism. Angew. Chem. Int. Ed. 2018;57:2377–2382. doi: 10.1002/anie.201712453. [DOI] [PubMed] [Google Scholar]
  • 24.Arad E, et al. Lysine‐derived carbon dots for chiral inhibition of prion peptide fibril assembly. Adv. Ther. 2018;1:1800006. [Google Scholar]
  • 25.Hu L, et al. Chiral evolution of carbon dots and the tuning of laccase activity. Nanoscale. 2018;10:2333–2340. doi: 10.1039/c7nr08335a. [DOI] [PubMed] [Google Scholar]
  • 26.Zhang M, et al. Maltase decorated by chiral carbon dots with inhibited enzyme activity for glucose level control. Small. 2019;15:1901512. doi: 10.1002/smll.201901512. [DOI] [PubMed] [Google Scholar]
  • 27.Zhang M, et al. Chiral control of carbon dots via surface modification for tuning the enzymatic activity of glucose oxidase. ACS Appl. Mater. Inter. 2021;13:5877–5886. doi: 10.1021/acsami.0c21949. [DOI] [PubMed] [Google Scholar]
  • 28.Li RS, et al. Chiral nanoprobes for targeting and long-term imaging of the Golgi apparatus. Chem. Sci. 2017;8:6829–6835. doi: 10.1039/c7sc01316g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zhang M, et al. One-step hydrothermal synthesis of chiral carbon dots and their effects on mung bean plant growth. Nanoscale. 2018;10:12734–12742. doi: 10.1039/c8nr01644e. [DOI] [PubMed] [Google Scholar]
  • 30.Srivastava I, et al. On-chip electrical monitoring of real-time “soft” and “hard” protein corona formation on carbon nanoparticles. Small Methods. 2020;4:2000099. [Google Scholar]
  • 31.Feliu N, et al. Nanoparticle dosage-a nontrivial task of utmost importance for quantitative nanosafety research. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2016;8:479–492. doi: 10.1002/wnan.1378. [DOI] [PubMed] [Google Scholar]
  • 32.Arcudi F, Dordevic L, Prato M. Design, synthesis, and functionalization strategies of tailored carbon nanodots. Acc. Chem. Res. 2019;52:2070–2079. doi: 10.1021/acs.accounts.9b00249. [DOI] [PubMed] [Google Scholar]
  • 33.Dordevic L, Arcudi F, Prato M. Preparation, functionalization and characterization of engineered carbon nanodots. Nat. Protoc. 2019;14:2931–2953. doi: 10.1038/s41596-019-0207-x. [DOI] [PubMed] [Google Scholar]
  • 34.Arcudi F, Đorđević L, Prato M. Synthesis, separation, and characterization of small and highly fluorescent nitrogen‐doped carbon nanodots. Angew. Chem. Int. Ed. 2016;55:2107–2112. doi: 10.1002/anie.201510158. [DOI] [PubMed] [Google Scholar]
  • 35.Dordevic L, et al. Design principles of chiral carbon nanodots help convey chirality from molecular to nanoscale level. Nat. Commun. 2018;9:3442. doi: 10.1038/s41467-018-05561-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Parakhonskiy B, et al. The influence of the size and aspect ratio of anisotropic, porous CaCO3 particles on their uptake by cells. J. Nanobiotechnol. 2015;13:53. doi: 10.1186/s12951-015-0111-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Talamini L, et al. Influence of size and shape on the anatomical distribution of endotoxin-free gold nanoparticles. ACS Nano. 2017;11:5519–5529. doi: 10.1021/acsnano.7b00497. [DOI] [PubMed] [Google Scholar]
  • 38.Credi A, Prodi L. From observed to corrected luminescence intensity of solution systems: an easy-to-apply correction method for standard spectrofluorimeters. Spectrochim. Acta A. 1998;54:159–170. [Google Scholar]
  • 39.Röcker C, Pötzl M, Zhang F, Parak WJ, Nienhaus GU. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat. Nanotechnol. 2009;4:577–580. doi: 10.1038/nnano.2009.195. [DOI] [PubMed] [Google Scholar]
  • 40.Jiang X, et al. Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding. J. R. Soc. Interface. 2010;7:S5–S13. doi: 10.1098/rsif.2009.0272.focus. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.del Pino P, et al. Protein corona formation around nanoparticles-from the past to the future. Mater. Horiz. 2014;1:301–313. [Google Scholar]
  • 42.Hühn J, et al. Dissociation coefficients of protein adsorption to nanoparticles as quantitative metrics for description of the protein corona: a comparison of experimental techniques and methodological relevance. Int. J. Biochem. Cell Biol. 2016;75:148–161. doi: 10.1016/j.biocel.2015.12.015. [DOI] [PubMed] [Google Scholar]
  • 43.Chakraborty S, et al. Contrasting effect of gold nanoparticles and nanorods with different surface modifications on the structure and activity of bovine serum albumin. Langmuir. 2011;27:7722–7731. doi: 10.1021/la200787t. [DOI] [PubMed] [Google Scholar]
  • 44.Dominguez-Medina S, et al. Adsorption and unfolding of a single protein triggers nanoparticle aggregation. ACS Nano. 2016;10:2103–2112. doi: 10.1021/acsnano.5b06439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wang H, Ma R, Nienhaus K, Nienhaus GU. Formation of a monolayer protein corona around polystyrene nanoparticles and implications for nanoparticle agglomeration. Small. 2019;15:1900974. doi: 10.1002/smll.201900974. [DOI] [PubMed] [Google Scholar]
  • 46.Song Y, et al. Protein corona formation of human serum albumin with carbon quantum dots from roast salmon. Food Funct. 2020;11:2358–2367. doi: 10.1039/c9fo02967b. [DOI] [PubMed] [Google Scholar]
  • 47.Johnston BD, et al. Colloidal stability and surface chemistry are key factors for the composition of the protein corona of inorganic gold nanoparticles. Adv. Funct. Mater. 2017;27:1701956. [Google Scholar]
  • 48.Carril M, et al. In situ detection of the protein corona in complex environments. Nat. Commun. 2017;8:1542. doi: 10.1038/s41467-017-01826-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ashraf S, et al. Quantitative particle uptake by cells as analyzed by different methods. Angew. Chem. Int. Ed. 2020;59:5438–5453. doi: 10.1002/anie.201906303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Ma X, et al. Colloidal gold nanoparticles induce changes in cellular and subcellular morphology. ACS Nano. 2017;11:7807–7820. doi: 10.1021/acsnano.7b01760. [DOI] [PubMed] [Google Scholar]
  • 51.Liu Z, et al. Biodegradation of Bi-labeled polymer-coated rare-earth nanoparticles in adherent cell cultures. Chem. Mater. 2020;32:245–254. [Google Scholar]
  • 52.Lyapun I, Andryukov B, Bynina M. HeLa cell culture: immortal heritage of Henrietta lacks. Mol. Gen. Microbiol. Virol. 2019;34:195–200. [Google Scholar]
  • 53.Feliu N, et al. Stability and biocompatibility of a library of polyester dendrimers in comparison to polyamidoamine dendrimers. Biomaterials. 2012;33:1970–1981. doi: 10.1016/j.biomaterials.2011.11.054. [DOI] [PubMed] [Google Scholar]
  • 54.Carrillo-Carrion C, et al. Triple-labeling of polymer-coated quantum dots and adsorbed proteins for tracing their fate in cell cultures. ACS Nano. 2019;13:4631–4639. doi: 10.1021/acsnano.9b00728. [DOI] [PubMed] [Google Scholar]
  • 55.Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6:662–668. doi: 10.1021/nl052396o. [DOI] [PubMed] [Google Scholar]
  • 56.Xu M, et al. How entanglement of different physicochemical properties complicates the prediction of in vitro and in vivo interactions of gold nanoparticles. ACS Nano. 2018;12:10104–10113. doi: 10.1021/acsnano.8b04906. [DOI] [PubMed] [Google Scholar]
  • 57.Hartmann R, Weidenbach M, Neubauer M, Fery A, Parak WJ. Stiffness-dependent in vitro uptake and lysosomal acidification of colloidal particles. Angew. Chem. Int. Ed. 2015;54:1365–1368. doi: 10.1002/anie.201409693. [DOI] [PubMed] [Google Scholar]
  • 58.Nazarenus M, et al. In vitro interaction of colloidal nanoparticles with mammalian cells: what have we learned thus far? Beilstein J. Nanotech. 2014;5:1477–1490. doi: 10.3762/bjnano.5.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Baalousha M, Prasad A, Lead JR. Quantitative measurement of the nanoparticle size and number concentration from liquid suspensions by atomic force microscopy. Environ. Sci. Process. Impacts. 2014;16:1338–1347. doi: 10.1039/c3em00712j. [DOI] [PubMed] [Google Scholar]
  • 60.Hühn J, et al. Selected standard protocols for the synthesis, phase transfer, and characterization of inorganic colloidal nanoparticles. Chem. Mater. 2017;29:399–461. [Google Scholar]
  • 61.Maffre P, Nienhaus K, Amin F, Parak WJ, Nienhaus GU. Characterization of protein adsorption onto FePt nanoparticles using dual-focus fluorescence correlation spectroscopy. Beilstein J. Nanotechnol. 2011;2:374–383. doi: 10.3762/bjnano.2.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Hühn D, et al. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano. 2013;7:3253–3263. doi: 10.1021/nn3059295. [DOI] [PubMed] [Google Scholar]
  • 63.Mahmoudi M, et al. Temperature: the “ignored” factor at the nanobio interface. ACS Nano. 2013;7:6555–6562. doi: 10.1021/nn305337c. [DOI] [PubMed] [Google Scholar]
  • 64.Maffre P, et al. Effects of surface functionalization on the adsorption of human serum albumin onto nanoparticles—a fluorescence correlation spectroscopy study. Beilstein J. Nanotechnol. 2014;5:2036–2047. doi: 10.3762/bjnano.5.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Pelaz B, et al. Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake. ACS Nano. 2015;9:6996–7008. doi: 10.1021/acsnano.5b01326. [DOI] [PubMed] [Google Scholar]
  • 66.Culbertson CT, Jacobson SC, Ramsey JM. Diffusion coefficient measurements in microfluidic devices. Talanta. 2002;56:365–373. doi: 10.1016/s0039-9140(01)00602-6. [DOI] [PubMed] [Google Scholar]
  • 67.Caballero-Díaz E, et al. The toxicity of silver nanoparticles depends on their uptake by cells and thus on their surface chemistry. Part. Part. Syst. Char. 2013;30:1079–1085. [Google Scholar]
  • 68.Sri S, Kumar R, Panda AK, Solanki PR. Highly biocompatible, fluorescence, and Zwitterionic carbon dots as a novel approach for bioimaging applications in cancerous cells. ACS Appl. Mater. Inter. 2018;10:37835–37845. doi: 10.1021/acsami.8b13217. [DOI] [PubMed] [Google Scholar]
  • 69.Doshi N, Mitragotri S. Macrophages recognize size and shape of their targets. PLoS ONE. 2010;5:e10051. doi: 10.1371/journal.pone.0010051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 1999;17:593–623. doi: 10.1146/annurev.immunol.17.1.593. [DOI] [PubMed] [Google Scholar]
  • 71.Carpenter A, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100. doi: 10.1186/gb-2006-7-10-r100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Hsieh CW, Chu CH, Lee HM, Yuan Yang W. Triggering mitophagy with far-red fluorescent photosensitizers. Sci. Rep. 2015;5:10376. doi: 10.1038/srep10376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Zhu D, et al. Intracellularly disintegratable polysulfoniums for efficient gene delivery. Adv. Funct. Mater. 2017;27:1606826. [Google Scholar]
  • 74.Yan H, et al. Facile synthesis of semi-library of low charge density cationic polyesters from poly (alkylene maleate)s for efficient local gene delivery. Biomaterials. 2018;178:559–569. doi: 10.1016/j.biomaterials.2018.03.050. [DOI] [PubMed] [Google Scholar]
  • 75.Liu X, et al. Fusogenic reactive oxygen species triggered charge-reversal vector for effective gene delivery. Adv. Mater. 2016;28:1743–1752. doi: 10.1002/adma.201504288. [DOI] [PubMed] [Google Scholar]
  • 76.Manders EMM, Verbeek FJ, Aten JA. Measurement of colocalization of objects in dual-color confocal images. J. Microsc-Oxf. 1993;169:375–382. doi: 10.1111/j.1365-2818.1993.tb03313.x. [DOI] [PubMed] [Google Scholar]
  • 77.Zhu D, et al. Detailed investigation on how the protein corona modulates the physicochemical properties and gene delivery of polyethylenimine (PEI) polyplexes. Biomater. Sci. 2018;6:1800–1817. doi: 10.1039/c8bm00128f. [DOI] [PubMed] [Google Scholar]
  • 78.Roy S, Elbaz NM, Parak WJ, Feliu N. Biodegradable alginate polyelectrolyte capsules as plausible biocompatible delivery carriers. ACS Appl. Bio. Mater. 2019;2:3245–3256. doi: 10.1021/acsabm.9b00203. [DOI] [PubMed] [Google Scholar]
  • 79.Semmling M, et al. A novel flow-cytometry-based assay for cellular uptake studies of polyelectrolyte microcapsules. Small. 2008;4:1763–1768. doi: 10.1002/smll.200800596. [DOI] [PubMed] [Google Scholar]
  • 80.Wang Y, Ledgerwood C, Grills C, Fitzgerald DC, Hamilton PW. A robust co-localisation measurement utilising z-stack image intensity similarities for biological studies. PLoS ONE. 2012;7:e30632. doi: 10.1371/journal.pone.0030632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Lulevich V, Shih YP, Lo SH, Liu GY. Cell tracing dyes significantly change single cell mechanics. J. Phys. Chem. B. 2009;113:6511–6519. doi: 10.1021/jp8103358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Kastl L, et al. Multiple internalization pathways of polyelectrolyte multilayer capsules into mammalian cells. ACS Nano. 2013;7:6605–6618. doi: 10.1021/nn306032k. [DOI] [PubMed] [Google Scholar]
  • 83.Srivastava KD, Magazine HI. Thrombin receptor activation inhibits monocyte spreading by induction of ETB receptor-coupled nitric oxide release. J. Immunol. 1998;161:5039–5044. [PubMed] [Google Scholar]
  • 84.Kapellos TS, et al. A novel real time imaging platform to quantify macrophage phagocytosis. Biochem. Pharmacol. 2016;116:107–119. doi: 10.1016/j.bcp.2016.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Akita H, et al. Particle tracking of intracellular trafficking of octaarginine-modified liposomes: a comparative study with adenovirus. Mol. Ther. 2010;18:955–964. doi: 10.1038/mt.2010.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Inoue S, Setoyama Y, Odaka A. Phagocytosis of bafilomycin A1-treated apoptotic neuroblastoma cells by bone marrow-derived dendritic cells initiates a CD8α+ lymphocyte response to neuroblastoma. Pediatr. Hematol. Oncol. J. 2014;36:e290–e295. doi: 10.1097/MPH.0000000000000060. [DOI] [PubMed] [Google Scholar]
  • 87.Frankenberg T, Kirschnek S, Häcker H, Häcker G. Phagocytosis‐induced apoptosis of macrophages is linked to uptake, killing and degradation of bacteria. Eur. J. Immunol. 2008;38:204–215. doi: 10.1002/eji.200737379. [DOI] [PubMed] [Google Scholar]
  • 88.Popena I, et al. Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages. Cell Commun. Signal. 2018;16:1–12. doi: 10.1186/s12964-018-0229-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Mano M, Teodosio C, Paiva A, Simoes S, de Lima MCP. On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide. Biochem. J. 2005;390:603–612. doi: 10.1042/BJ20050577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 2004;10:310–315. doi: 10.1038/nm996. [DOI] [PubMed] [Google Scholar]
  • 91.Chen F, et al. Clathrin-mediated endocytosis is a candidate entry sorting mechanism for Bombyx mori cypovirus. Sci. Rep. 2018;8:1–11. doi: 10.1038/s41598-018-25677-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information (21.6MB, docx)
Peer Review File (5.6MB, pdf)
Reporting Summary (367.5KB, pdf)

Data Availability Statement

The data supporting the findings of this study are either provided in the article and its Supplementary Information or available from the corresponding authors upon request.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES